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1.1  Introduction 
Every year about 250 million people worldwide get malaria infection and about 
one million deaths are estimated to occur due to this infection (WHO, 2009). 
Plasmodium falciparum is the most virulent of the four common species of human 
malaria. Others are P. vivax, P. ovale and P. malariae. Most of malaria cases admitted 
to hospitals as well as those leading to fatality are due to P. falciparum of which children 
under five years of age and pregnant women are most affected. Grave complications 
observed in malaria infection such as severe anemia, respiratory distress, lactic acidosis 
and cerebral malaria manifested with coma, and multiple organ damage (Marsh et al., 
1995; Molyneux et al., 1989) are characteristic of P. falciparum malaria. The tendency of 
the P. falciparum-infected erythrocytes to sequester and adhere to tissues, especially the 
endothelium of micro-capillaries is a major contributor to the severe symptoms of the 
disease (Dondorp et al., 1999; Dondorp et al., 2004). It has been shown that malaria 
infection is marked with oxidative stress and the latter underlies most pathological 
symptoms (Becker et al., 2004; Postma et al., 1996; Hunt and Stocker, 1990).  
Malaria-induced oxidative stress arises from two main sources: first, as a result of 
the high metabolic rate of the rapidly growing and multiplying parasite within the 
erythrocyte and secondly as the result of the host immune response to the infection. 
With degradation of host hemoglobin by the parasite large quantities of toxic and redox-
active byproducts are produced. Hemoglobin digestion within the parasite’s acidic food 
vacuole releases toxic ferroprotoporphyrin IX (FP) and reactive oxygen species (ROS) 
(Postma et al., 1996). Normally most of the released FP is polymerized into crystalline 
hemozoin or malaria pigment (Egan et al., 2002; Francis et al., 1997). However, it has 
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been shown that a significant amount of FP escapes polymerization and has to be 
detoxified in the cytoplasm by other processes to prevent damage of proteins, lipids, and 
nucleic acids (Zhang et al., 1999). Free FP can interact with phospholipid membranes 
causing structural defects due to the reactivity of its attached Fe3+ with unsaturated 
membrane lipids. This can lead to increased membrane permeability for ions, cell 
swelling and lysis  (Famin et al., 1999; Fitch et al., 1982; Orjih et al., 1981). This fraction 
of FP is detoxified by glutathione-dependent pathways and FP-binding proteins (Famin 
and Ginsburg, 2002; Zhang et al., 1999). The host immune system, either in response to 
antigen presentation or to sequestered parasites, secretes a number of cytokines 
including tumor necrosis factor-alpha (TNF-α) which trigger inflammatory reactions 
leading to increase in ROS through mechanisms such as respiratory burst by 
macrophages. In addition, reoxygenation of hypoxic tissues that were priory blocked by 
sequestering parasites can contribute to ROS production (Becker et al., 2004).  
The effect of ROS in malaria can be both beneficial and detrimental depending on 
the amount and place of production (Postma et al., 1996). While malaria pathology can 
be attributed to an increase in oxidative stress, the latter is important in malaria 
clearance as the most potent antimalarial drugs are thought to act by increasing 
oxidative stress. In this chapter we discuss the mechanisms involved in detoxification of 
malaria-induced ROS both in the parasite and in the host cell, with emphasis on the 
glutathione metabolism. The potential of these systems as targets for new therapeutic 
strategies is also discussed.  
  
                                                                                                                                                
 Chapter 1 
  
 - 13 - 
 
1.2 Cellular antioxidant systems 
Most eukaryotic cells contain five major antioxidant enzymes namely superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione S-
transferases (GST) and peroxiredoxins (Prx) (Kawazu et al., 2008). In this section the 
antioxidant enzymes have been grouped into three categories (Table 1.1). The first 
system includes the SOD and CAT forming the first line defense against superoxide and 
hydrogen peroxide, secondly the thioredoxin-dependent system that includes Prx and 
utilizes electrons supplied by the thiol groups of thioredoxins to reduce their targets, 
and thirdly GST that obtains electrons from glutathione. Since GPx overlaps with CAT 
functions it will be discussed together with SOD and CAT (Fig. 1.1). 
1.2.1  Superoxide dismutase, catalase and glutathione peroxidase 
SODs are metalloproteins that use copper/zinc (Cu/Zn), iron (Fe) or manganese 
(Mn) as cofactors (Fridovich, 1995). Superoxide dismutases are named after their role in 
dismutation of superoxide radicals (O2-) to hydrogen peroxide (H2O2) and oxygen (O2). 
Three mammalian SODs are distinguished as cytosolic Cu/Zn-SOD, extracellular 
Cu/Zn-SOD (usually referred as EC-SOD) and mitochondrial Mn-SOD (Fridovich, 
1997). CAT is an ubiquitous enzyme predominantly present in peroxisomes in 
mammalian and protozoan cells. In the erythrocytes it is found in the cytosol (Bosch et 
al., 1992). GPx like CAT is ubiquitous with cytosolic and extracellular isoforms (Muller 
et al., 2007). CAT and GPx limit the accumulation of H2O2. H2O2 functions as a substrate 
for the Fenton reaction to generate the highly reactive hydroxyl radical (HO•).  
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Generally SOD, CAT, and GPx form the first line of defense against ROS. GPx is 
thought to exhibit a lower Km value for H2O2 compared to CAT (Flohe et al., 1972) and it 
is speculated that GPx removes H2O2 at low concentrations while CAT is more efficient 
at higher concentrations (Makino et al., 1994), but this is still debatable (Mueller et al., 
1997b; Mueller et al., 1997a). Studies in mice indicate that inactivation of the 
mitochondrial Mn-SOD leads to lethal consequences such as increased sensitivity to 
normoxia and hyperoxia, delayed neonatal lung development and early death 
(Asikainen et al., 2002), persistent hemolytic anemia, RBC protein oxidative damage, 
cell deformation and cell death induced by oxygen injury (Friedman et al., 2001). This 
condition could be corrected by treatment with catalytic antioxidant with catalase and 
SOD activity (Friedman et al., 2001). On the other hand, mice deficient of the cytosolic 
enzymes CAT or GPx1 did not develop hemolysis or show increased sensitivity to 
hyperoxia (Johnson et al., 2000; Ho et al., 1997) and acatalasemic mice still grew 
normally and showed no increased sensitivity to hyperoxia compared to their wild type 
littermates, although they had a decreased ability to remove H2O2 (Ho et al., 2004). 
These findings made the authors propose a limited role of either CAT or GPx in defense 
against ROS (Ho et al., 1997; Ho et al., 2004), but this is still disputable. Moreover, 
these reports were based on single gene knockouts, hence double knockouts of both CAT 
and GPx may have a different outcome due to their combined role on ROS. 
Nevertheless, these findings altogether highlight the existence of alternative antioxidant 
systems with substrate overlap that can compensate one another. In malaria, FP-
induced ROS is thought to be the major source of erythrocytic oxidative stress burden, 
which can also affect the functioning of the immune system. This is supported by the 
fact that chronic inflammatory reactions caused by infection or cancer can cause ROS-
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induced inactivation of T-cells and natural killer (NK) cells (Baniyash, 2006; Kiessling 
et al., 1999; Nagaraj et al., 2007). In a recent study, (Ando et al., 2008) human immune 
cells (CD4+ and CD8+ cells) were protected against ROS-induced inactivation and 
apoptosis by transducing them with CAT. CAT, GPx and the Cu/Zn-SODs therefore form 
a very important defense system not only within the P. falciparum infected RBC but also 
in immune cells and the peripheral tissues where parasitized RBCs sequester and induce 
ROS formation. 
1.2.2 Thioredoxin-dependent system 
The thioredoxin system is composed of the small dithiol oxidoreductase, 
thioredoxin (Trx) and peroxiredoxins (Prx). Trxs reduce protein disulfides and are 
maintained in the reduced state by the enzyme thioredoxin reductase (TrxR), obtaining 
the electrons from NADPH (Lillig and Holmgren, 2007). Thioredoxins have a conserved 
Cys-Gly-Pro-Cys (CGPC) active site (Lillig and Holmgren, 2007). The conserved cysteine 
thiol groups are central for the reducing function of this system. Mammalian cells 
contain three thioredoxins, Trx1 which is primarily cytosolic but can also translocate to 
the nucleus (Masutani et al., 1996), a mitochondrial Trx2 (Spyrou et al., 1997) and a 
specific testis Trx-glutathione reductase (TGR) (Sun et al., 2001). Mammalian 
thioredoxin systems are known to protect against oxidative stress (Lillig and Holmgren, 
2007).  
Prx are thiol-dependent peroxidases and are found in all living organisms (Lillig 
and Holmgren, 2007). The function of Prxs in higher animals is complex and ranges 
from antioxidant defense to redox regulation through cellular signaling using H2O2 as a 
messenger (Bae et al., 2009; Hashemy and Holmgren, 2008; Lillig and Holmgren, 
2007). Currently, six human peroxiredoxins have been identified and named Prx1 
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through 6. Prx1 to 5 obtain electrons from Trx, while Prx6 relies on GSH for electrons by 
being glutathionylated by glutathione S-transfease-Pi (Manevich et al., 2004). This 
property makes Prx6 unique from other Prxs and links the peroxiredoxin system with 
the glutathione system. Prx6 plays a major role in antioxidant function and is expressed 
predominantly in lung epithelium. Prx6 was able to reduce phospholipid 
hydroperoxides in a very efficient pathway (Fisher et al., 1999). Mice with Prx6 gene 
inactivation were more susceptible to induced oxidative stress lung damage than the 
wild type (Wang et al., 2004; Wang et al., 2006; Wang et al., 2008). Prx1, expressed 
ubiquitously as cytosolic protein, is abundant in erythrocytes and enhances the 
cytotoxicity of natural killer (NK) cells (Shau et al., 1993). More importantly, Prx1 was 
shown to have high affinity for heme in hepatocytes (Iwahara et al., 1995). Perhaps Prx1 
may have a role in FP detoxification especially in the oxidatively stressed erythrocytes. 
Targeted gene inactivation in mice led to severe hemolytic anemia, several malignancies 
and shortened erythrocyte life span due to oxidative damage to proteins and DNA in 
aging mice (Neumann et al., 2003). Furthermore, these effects also occurred in the 
heterozygous Prx1-deficient mice whose Prx1 level are about 50% of that in wild type, 
thus emphasizing the requirement for large amounts of Prx1 for cell survival (Neumann 
et al., 2003). Another important erythrocyte antioxidant, Prx2 has been shown to 
exhibit a high reactivity against H2O2 at a rate comparable to that of catalase and 
glutathione peroxidase, suggesting Prx2 to be a H2O2 scavenger (Peskin et al., 2007). At 
the same time the high specificity for H2O2 indicates a possibility for Prx2 to serve as a 
signaling molecule via H2O2 (Peskin et al., 2007). In malaria infection host cell defense 
mechanisms against oxidative damage from parasite metabolites such as FP and ROS 
possibly include such proteins as human Prx1. So far no reports are available on the role 
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of host Prx defense against malarial FP-induced ROS. Such information would broaden 
our understanding on the host defense against malarial toxins, while identification of 
parasite homologues would help in the search for new therapeutic targets. 
1.2.3 Glutathione-dependent system  
The important feature of this system is the utilization of the tripeptide 
glutathione (GSH) as the central electron donor. GSH is synthesized in a two step 
reaction pathway catalyzed by two enzymes, γ-glutamylcysteine synthetase (γ-
glutamate-cysteine ligase) and glutathione synthetase. During redox reactions GSH 
becomes oxidized to glutathione disulfide (GSSG), which normally is reduced by 
glutathione reductase (GR) and NADPH. In turn, the resulting NADP+ is reduced back 
to NADPH through the enzymes of the pentose phosphate pathway, glucose-6-
phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Moreover, GSSG 
formed during this reaction together with conjugation products resulting from GST 
activity can be actively extruded across biological membranes by ATP-dependent 
multidrug resistance transporters (MRPs) (see paragraph 1.4). Enzymes involved in the 
GSH-dependent system include GPx, GSTs and glutaredoxins (Grx). GPx are part of the 
first line of defense against ROS, together with catalase they reduce H2O2 to O2 and H2O. 
Additionally, GPx reduce organic peroxides and hydroperoxides such as lipid peroxides 
and hydroperoxides (Lu and Holmgren, 2009). Grx are low molecular weight thiol 
proteins that belong to the thioredoxin family and are peroxidases in nature just like 
peroxiredoxins. The difference is that for electrons Grx relies on GSH, whereas Prx 
relies on Trx (Collinson et al., 2002). Moreover, Grx, unlike Trx, reduces both 
monothiols and dithiols. Furthermore, Grx has been found to function as GSTs in the 
yeast Saccharomyces cerevisiae (Collinson and Grant, 2003). It has also been shown 
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that Grx can be reduced by dihydrolipoamide, which places this molecule in a bridging 
position between cytoplasmic and mitochondrial redox systems (Porras et al., 2002). 
Two mammalian Grx have been identified, a cytosolic Grx1 and a mitochondrial Grx2. 
Grx1 fuels the ribonucleotide reductase (RNR) with electrons and is involved in various 
redox-controlled cellular processes such as cell differentiation, regulation of 
transcription factors and apoptosis (Lillig and Holmgren, 2007; Shelton et al., 2005). 
Grx2 has been characterized as a mitochondrial oxidoreductase belonging to the Fe-S 
cluster. Recently isoforms of Grx2, Grx2b and Grx2c have been characterized and were 
found to localize both in the cytosol and nucleus (Lonn et al.,2008). Mitochondrial Grx2 
is thought to catalyze glutathionylation/ deglutathionylation of mitochondrial thiol 
proteins accepting electrons from either GSH or from TrxR (Beer et al., 2004). In yeast 
Grx1 and Grx2 were shown to protect against H2O2 and cumene hydroperoxide and 
overexpression conferred resistance against H2O2 (Collinson et al., 2002). Full 
characterization of homologous members of this group in parasitic organisms can offer 
promising future drug targets. 
GSTs constitute a large superfamily of ubiquitous phase-II detoxification 
enzymes catalyzing nucleophilic conjugation attack by glutathione to a wide range of 
hydrophobic compounds. This conjugation usually renders hydrophobic compounds 
more water soluble and predisposes them to excretion from the cell (Hayes et al., 2005). 
Additionally, some GSTs possess peroxidase activity and can detoxify lipid peroxides 
and hydroperoxides protecting cells from reactive radical injury (Bruns et al., 1999; 
Collinson et al., 2002; Zhao et al., 1999). GSTs also can play a role in cellular signaling, 
regulation of transcription and in stress response (Salinas and Wong, 1999). GSTs can 
be classified into four major families namely cytosolic GSTs, mitochondrial GSTs, 
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microsomal GSTs and the exclusive bacterial fosfomycin-resistance protein (Allocati et 
al., 2009). The mitochondrial GSTs consist of the kappa class which forms part of the 
soluble GSTs present in eukaryotes. The microsomal GSTs also referred to as 
membrane-associated proteins involved in eicosanoid and glutathione metabolism 
(MAPEG) are unrelated to the soluble GSTs (Jakobsson et al., 1999). They are 
membrane-bound GSTs that are also involved in cellular signaling as well as 
detoxification of ROS (Frova, 2006). Cytosolic GSTs are further classified into about 15 
classes namely: alpha, mu, pi, theta, sigma, omega and zeta. Others are lambda, phi, tau, 
delta, epsilon, chi, beta and dehydroascorbate reductase (DHAR) (Allocati et al 2008; 
Frova, 2006). Wilst GST theta and zeta are ubiquitous, GST alpha, mu, and pi are found 
in mammals,  phi, lambda, tau, and DHAR in plants, delta in insects, omega in both 
mammals and insects, and beta and chi are found in bacteria (Allocati et al., 2009; 
Frova, 2006). GSTs show highly conserved characteristic amino acid motifs especially in 
the glutathione recognition site, although the active site residues involved in GSH 
binding vary among classes. Alpha, mu, and pi classes maintain a tyrosine in the GSH-
binding site; theta, zeta, phi, tau, and delta contain a serine, whereas omega, beta, 
lambda, and DHAR contain a cysteine at this position (Frova, 2006). The residue in the 
GSH binding site of GST-chi is unknown (Allocati et al., 2009). GST-alpha, mu, pi and 
theta are expressed in erythrocytes and lymphoid cells (Wang et al., 2000) and could 
thus play important roles in defense against ROS. 
The role of GSTs in defense against ROS has been thoroughly investigated in 
human ROS-associated diseases (Strange et al., 2000; Wang et al., 2000; Ye and Song, 
2005; Zhao et al., 1999; Millard et al., 2008). Erythrocyte GSTs are involved in binding 
and detoxification of heme (Harvey and Beutler, 1982) and an increase in total 
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erythrocyte GST activity with decrease in GSTM  in various types of anemia has been 
reported (Chiang et al., 2007). GSTP1 is capable of reacting directly with reactive oxygen 
species such as lipid peroxides, and its activity can be induced by oxidative stress (Xia et 
al., 1996). GSTP1 can   also regulate  stress kinases (Kamada et al., 2004).    In    malaria,  
 
Table 1.1: Cellular antioxidant enzyme systems classified into three categories based on the 
source of reducing equivalents/electron. 
System  Reducing equivalents 
/electrons source 
Components  Abbreviations 
SOD and CAT Copper/Zink or Manganese Superoxide dismutase SOD 
Selenium  Catalase  CAT 
    
Thioredoxin- 
dependent 
system 
NADPH and Thioredoxin  
(-SH) 
Thioredoxin  Trx 
Peroxiredoxin / 
thioredoxin- dependent 
peroxidase 
 
Prx / TPx 
Plasmoredoxin (in 
Plasmodium) 
Plrx  
Thioredoxin reductase  TrxR 
    
Glutathione- 
dependent 
system 
NADPH and Glutathion   
(-SH) 
Glutathione GSH 
Glutathione peroxidase GPx 
Glutathione S 
transferase 
GST 
Glutaredoxin Grx  
Ribonucleotide 
reductase  
RNR 
Glutathione reductase  GR 
Glutaredoxin reductase GrxR 
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serum lipid peroxidation and catalase activity were higher in uncomplicated 
Plasmodium vivax infected patients than in healthy controls; whereas total serum GST 
activity was lower (Sohail et al., 2007).   
 
1.3 Redox systems in the malaria parasites  
As the Plasmodium parasites are highly exposed to reactive oxygen species, they 
need specialized antioxidant systems to overcome this problem. Several antioxidant 
enzymes have been identified and characterized (Fig.1.1). Since the malaria parasite 
does not express CAT or a genuine GPx (Becker et al., 2003b), the parasite’s antioxidant 
system falls into three major categories: (i) superoxide dismutase (SOD), (ii) glutathione 
and glutathione-dependent systems comprising glutathione, glutathione reductase 
(GR), glutathione S-transferase (GST) and glutaredoxin (Grx) and (iii) thioredoxin and 
thioredoxin-dependent systems comprising of NADPH, thioredoxin (Trx), thioredoxin 
reductase (TrxR) and thioredoxin-dependent peroxiredoxin (TPrx) (Buchholz et al., 
2008; Sturm et al., 2009b). 
1.3.1 Superoxide dismutase (SOD) system 
The structural classification of P. falciparum SOD is similar to the mammalian 
system. P. falciparum expresses two SODs, a cytosolic Fe-SOD (PfSOD-1) that is 
expressed throughout the erythrocytic stages of the parasite and a mitochondrial SOD-2. 
(Muller, 2004). 
1.3.2 Thioredoxin and thioredoxin-dependent systems 
In the P. falciparum five TPrx have been identified and characterized (Nickel et 
al., 2006; Rahlfs et al., 2002). These include one 1-Cys TPx, two typical 2-Cys TPxs 
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(PfTPx1 and PfTPx2), a 1-Cys antioxidant protein (AOP), and a GSH peroxidase-like 
thioredoxin peroxidase (GPTPx) (Nickel et al., 2006; Rahlfs et al., 2002). The 1-Cys TPx 
and one of the 2-Cys Prxs (PfTPrx-1) (Kawazu et al., 2000; Krnajski et al., 2001; 
Krnajski et al., 2001; Rahlfs and Becker, 2001) are expressed in the cytosol, and the 
other 2-Cys TPrx (PfTPx-2) is expressed in mitochondria (Boucher et al., 2006; Rahlfs 
and Becker, 2001). The AOP bears an apicoplast target signal peptide (Nickel et al., 
2006) while the GPTPx locatilization is yet to be identified (Sarma et al., 2005). Further 
to this, three thioredoxins (Trx) have been characterized namely Trx1 which is a 
cytosolic thioredoxin and Trx2 and Trx3 both of which are located in the apicoplast. 
These proteins fuel electrons to the thioredoxin-dependent system (Kanzok et al., 2000; 
Nickel et al., 2006). Additionally two Trx-like proteins (Tlp1 and Tlp2) have been 
identified in the parasite genome. Tlp1 is thought to be a dynein regulator while Tlp2 
function is unknown (Nickel et al., 2006). The parasite also expresses a Trx reductase 
(TrxR), which is a FAD-dependent oxidoreductase (Becker et al., 2004; Muller, 2004). 
PfTrxR has a C-terminal active site motif that differs from that of human TrxR (Becker 
et al., 2004; Muller, 2004). Initially gene knockouts revealed that PfTrxR is essential for 
the asexual stage development of the parasite (Krnajski et al., 2002). P. falciparum also 
expresses a typical glutaredoxin (Grx) and Grx-like proteins (Deponte et al., 2005; 
Rahlfs et al., 2001) that are GSH dependent and donate electrons to AOP (Nickel et al., 
2006). Moreover, a unique thioredoxin protein, plasmoredoxin (Plrx) has been 
characterized from the parasite. Plrx bridges the Trx and GSH systems in the malaria 
parasite (Becker et al., 2003a) and donates electrons to PfTPx-1 (Nickel et al., 2005). 
The uniqueness of the Plrx to Plasmodium makes it an attractive target for drug 
development strategies. However, gene knockout studies have shown that Plrx deficient 
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P. berghei parasites were able to grow normally even under enhanced oxidative stress in 
vivo and were not different from wild types throughout the complete life cycle 
(Buchholz et al., 2008). The depletion of Plrx did not have a significant change in the 
expression levels of other members of the thioredoxin system such as TrxR or Grx. 
Although the authors proposed a non-essential role for the Plrx system, these findings 
may explain the possible overlap between antioxidant systems especially from the 
thioredoxin and glutathione dependent systems. Also the diversity among the members 
of the thioredoxin family systems may represent redundancy in activity. Should this be 
the case, single gene knockouts may not produce significant effect, rather multiple gene 
knockouts may be more informative. It is believed that GSH is the major redox buffer 
for transient H2O2 exposure and that the basal cellular peroxide flux in the parasite is 
handled by the Trx system (Kawazu et al., 2008). 
1.3.3 Glutathione and glutathione-dependent systems 
In the Plasmodium parasite, GSH forms a central antioxidant defense system. 
Although not clearly understood, the parasite’s GSH system seems to be very crucial for 
survival and has been a major focus for therapeutic interventions. Under normal 
metabolism the parasite suffers serious oxidative stress as deduced from the presence of 
a large number of carbonylated parasite proteins (Radfar et al., 2008). Treatment of 
parasite cultures with chloroquine increased protein carbonylation, indicating that 
indeed carbonylation was due to oxidative stress (Radfar et al., 2008). Moreover, a 
recent study has demonstrated that inhibition of GSH synthesis through disruption of γ-
glutamylcysteine synthetase inhibited sporozoite development in the mosquito (Vega-
Rodriguez et al., 2009). Although the authors found less effect of GSH depletion on the 
erythrocytic stages, their findings may imply existence of an alternative source of GSH 
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during erythrocytic stages, such as host GSH, which may be lacking in the mosquito. It 
has been shown that an appreciable amount of FP escapes polymerization in the food 
vacuole (Famin and Ginsburg, 2002) and is detoxified by other mechanisms that require 
GSH. For instance, in the P. falciparum trophozoite stage 30-95% FP was converted to 
hemozoin (Ginsburg et al., 1998; Egan et al., 2002). As a generally understood 
mechanism of action, quinoline antimalarial drugs such as chloroquine and 
amodiaquine bind to FP and inhibit polymerization into hemozoin (Fig.1.1) causing its 
accumulation in the parasite’s digestive vacuole (Foley and Tilley, 1997; Ridley et al., 
1997). It has been proposed that the drugs bind to FP and incorporate into the growing 
polymer forming drug-FP complex thus preventing further extension and consequently 
accumulation of the toxic FP and parasite death (Slater, 1993; Sullivan et al., 1996). It is 
further suggested that the inhibition of FP polymerization alone may not be sufficient to 
explain the killing of the parasite by the quinolines. The amount of FP that remains 
unpolymerized and leaves the food vacuole is very high even in the absence of drugs, 
suggesting additional mechanisms through which the drug exerts its action (Zhang et 
al., 1999). Indeed, GSH was shown to non-enzymatically degrade FP at a Km value of 
0.64 mM, which is below the normal concentration range of cellular GSH in the parasite 
(2.4 mM) and trophozoite-infected RBC (1.1 mM) (Famin et al., 1999). This indicates the 
relevance of the GSH-dependent FP detoxification pathway in the in vivo situation. 
GSTs are capable of binding FP (Harvey and Beutler, 1982) and thus can be utilized by 
the parasite to degrade free FP. Since there is no GPx in Plasmodium the GSH-
dependent system includes only GSTs and Grxs. The Grx system is yet to be fully 
understood. In bacterial cells, exposure to H2O2 leads to increased GST mRNA levels 
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and protein expression (Allocati et al., 2003) and GST-beta knockouts were more 
sensitive to H2O2 than the wild type (Kanai et al., 2006). 
To date only one GST has been identified in the P. falciparum parasite (Liebau et 
al., 2002). This PfGST shares only 37% sequence identity with known GST family 
members and represents a novel class of GSTs. It has a close identity with the pi-class 
GSTs from invertebrates (Tripathi et al., 2008). Another exceptional feature of PfGST is 
its existence as a tetramer in absence of GSH and as a dimer in presence of GSH, unlike 
other GSTs, which exist only as dimers. It has been demonstrated that PfGST is active in 
the dimeric form (Tripathi et al., 2008). PfGST exhibited selenium-independent 
peroxidase activity against cumene hydroperoxide, which suggests the possibility of 
PfGST involvement in GSH-dependent peroxidase as P. falciparum lacks a classical 
GSH-peroxidase (Liebau et al., 2002). PfGST was found to be inhibited by a number of 
compounds including FP (Harwaldt et al., 2002; Liebau et al., 2002) and later was 
found to sequester FP in a GSH-dependent manner (Hiller et al., 2006). GSTs are 
involved in drug resistance and homologues of PfGST have been identified and 
characterized in other Plasmodium species (Na et al., 2007; Ahmad and Srivastava, 
2007). In chloroquine resistant parasites, GST activity was increased under drug 
pressure (Srivastava et al., 1999). In P. berghei, reticulocytes rich in GSH were preferred 
and parasites invading these cells acquired high IC50 value to chloroquine and reduced 
hemozoin formation, both of which were reversed by treatment with the gamma-
glutamylcysteine synthase inhibitor buthionine sulfoximine (BSO) (Platel et al., 1999). 
The uniqueness of the PfGST and its role in drug resistance as well as detoxification of 
heme makes it a good target for novel antimalarials. Currently several compounds with 
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PfGST inhibitory activities have shown promising results in in-vivo studies (see section 
1.5 and Table 1.2).  
 
1.4 Multidrug resistance transporters and glutathione 
transport in P. falciparum 
MRPs belong to the ATP-Binding Cassette (ABC) superfamily of transporters. 
This is one of the largest evolutionarily conserved protein families and most of its 
members are involved in the active transport of a wide range of substrates across 
membranes, including drugs and GSH-conjugated drugs and metabolites (Dassa and 
Bouige, 2001; Dean et al., 2001b). Structurally a typical ABC transporter consists of six 
hydrophobic transmembrane segments that form the transmembrane domain (TMD) 
and  two conserved motifs, Walker A and a hydrophobic region Walker B (Bozdech et 
al., 1996), that form the nucleotide binding domain (NBD) (Walker et al., 1982). Walker 
A and B motifs are separated by an interspersed loop of approximately 100 amino acids 
that contain the ABC transporter signature motif (Schneider and Hunke, 1998). 
Although a functional ABC transporter must consist of two TMDs and two NBDs, 
eukaryotic ABC transporters are encoded either as full transporters or as half 
transporters that upon expression combine to form a functional unit (Hyde et al., 1990). 
Apart from their normal physiological role, ABC transporters are well known for their 
involvement in various diseases either directly or indirectly by a mutation or through 
altered mode of their expression (Dean and Annilo, 2005; Klokouzas et al., 2003). 
In humans MRP1 and MRP4 can transport glutathione, glutathione conjugates 
and antimalarial drugs (Wu et al., 2005a). In the P. falciparum parasite a number of 
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ABC transporters exist. PfMDR1 has been extensively studied in both clinical and 
laboratory research. Polymorphisms and increased copy numbers of PfMDR1 are 
associated with multidrug resistance in malaria (Sanchez et al., 2008; Sidhu et al., 
2006). PfMDR2 is a heavy metal transporter that confers resistance to heavy metals 
(Rosenberg et al., 2006). 
In malaria, GSTs and GPxs generate GSSG which is thought to be extruded into 
the host cell cytosol for reduction and for replenishment of GSH. It is thought that the P. 
falciparum multidrug resistance proteins or other GSH efflux pumps are involved in the 
efflux of GSSG (Becker et al., 2004).  In Saccharomyces cerevisiae, GSTs were shown to 
be important in the detoxification of hydroperoxides in conjunction with glutaredoxins. 
The resulting products, which are presumed to be GSH conjugates or GSSG, 
accumulated in the absence of the GSH transporter homologue (ycf1) (Collinson et al., 
2002). These findings imply that glutathione efflux pumps are important in GST and 
glutaredoxin-dependent detoxification of peroxides in the yeast. In the P. falciparum 
genome several ABC transporters are encoded, some of which have been characterized 
or classified (Rubio and Cowman, 1994).  Among these genes two belong to the MRP 
subgroup and are identified as PfMRP1 and PfMRP2 (Nogueira et al., 2008; Klokouzas 
et al., 2004). Recently the ability of PfMRP1 to transport GSH and GSH-conjugated 
antimalarial drugs was demonstrated (Raj et al., 2009b), a finding that emphasizes the 
role of PfMRPs in oxidative stress and detoxification. This finding also attracts attention 
to this class of transporters as potential drug targets.  
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1.5 Drug development strategies 
1.5.1  Targeting the GSH-dependent system 
Looking primarily at the antioxidant systems, the malaria parasite relies mostly 
on the GSH system for handling its heme-induced oxidative stress. This is supported by 
the fact that chloroquine-resistant (CQR) parasites exhibit significantly higher GSH 
levels than drug-sensitive Plasmodium strains (Dubois et al., 1995) and depletion of 
GSH in infected erythrocytes restores chloroquine efficacy in drug-resistant strains 
(Davioud-Charvet et al., 2001). Furthermore, erythrocytes deficient in glucose-6-
phosphate dehydrogenase do not support efficient growth of P.falciparum parasites 
(Janney et al., 1986). In addition, chloroquine-sensitive (CQS) parasites invading 
reticulocytes (which are rich in GSH) developed high GSH and GST activities, reduced 
hemozoin accumulation and reduced sensitivity to CQ (Platel et al., 1999). Finally, this is 
demonstrated by the recent observation that depletion of GSH by disruption of γ-
glutamylcysteine synthetase compromises parasite development in the mosquito (Vega-
Rodriguez et al., 2009). In conclusion, these findings demonstrate the central role of 
GSH for parasite survival, an important feature that makes the GSH metabolic pathway 
of the parasite an attractive target for malarial therapeutics. 
Inhibition of GSH levels can be achieved by either inhibiting its production 
through γ-glutamylcysteine synthetase, the limiting step in the GSH synthesis, or by 
inhibiting glutathione reductase (GR) which recycles oxidized GSH. Currently, a number 
of compounds have been developed and are screened for their inhibitory potency 
against GR, GST, and γ-glutamylcysteine synthetase (Table 2). One of these compounds 
is menadione, a known inhibitor of mammalian GR and γ-glutamylcysteine synthetase. 
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Menadione, cibacron blue, and FP were found to inhibit PfGST non-competitively with 
Ki values of 80 µM, 0.4 µM and 13 µM respectively (Ahmad and Srivastava, 2008).  Two 
derivatives of the polyphenolic lactone compound, ellagic acid (EA), are also 
investigated.  EA is a known inhibitor of human GSTs and is used in the treatment of 
cancer (Das et al., 1984; Das et al., 1986). The two derivatives, flavellagic acid (FEA) and 
coruleoellagic acid (CEA) consist of one or two additional hydroxyl groups, respectively, 
introduced into the EA structure (Sturm et al., 2009a). Tested on recombinant human 
and plasmodial redox enzymes (GST, GR and TrxR) and on chloroquine resistant 
cultures, both compounds displayed strong antiplasmodial activity with ability to both 
inhibit and down-regulate expression of the Plasmodium antioxidant genes (Sturm et 
al., 2009a). CEA had a preference for human enzymes, with exception of P. falciparum 
GST, while FEA prefered the plasmodial enzymes. Furthermore, both compounds were 
effective against chloroquine resistant parasites with no cytotoxic effects on human cells 
(Sturm et al., 2009a). A dual-drug strategy has been employed and initial results are 
promising. A derivative of menadione and 4-aminoquinoline, 6-[2’-(3’-methyl)-1’,4’-
naphthoquinolyl]hexanoic acid (referred as M5) was designed to inhibit both heme 
polymerization and GR activity (Davioud-Charvet et al., 2001). The compound was 
found to have a high non-competitive inhibitory effect on both human and parasite GR 
at low nanomolar levels (Bauer et al., 2006; Davioud-Charvet et al., 2001; Biot et al., 
2004). This resulted in the development of another series of dual-drugs in that line. Two 
tertiary amides (6-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)hexanoic acid [2-(7-
chloroquinolin-4-ylamino)ethyl]-N-isopropylamide (referred as 34) and N-[2-(7-
chloroquinolin-4-ylamino)ethyl]-N′-isopropyl-2-[4-(3-methyl-1,4-dioxo-1,4-dihydro-
naphthalen-2-ylmethyl)phenyl]acetamide) (referred as compound 36) showed a high 
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potency against both sensitive and resistant parasites at concentrations below 12 nM 
(Friebolin et al., 2008).  Interestingly, these two compounds exhibited a small 
synergistic effect with artemisinin. Another dual-drug in a recent study, an acridone 
derivative, has been designed to incorporate heme polymerization inhibitor tricyclic 
structure and a side chain designed to enhance accumulation of the drug in the 
parasite’s food vacuole. Screening of this drug against sensitive and multidrug resistant 
parasites revealed a high efficacy in both cases, while it did not show toxicity in murine 
malaria models (Kelly et al., 2009). This drug referred to as T3.5 (3-chloro-6-(2-
dimethlyamino-ethoxy)-10-(2-dimethylamino-ethyl)-acridone) exhibited synergy with 
quinine and piperaquine in its action (Kelly et al., 2009). Based on the potential of these 
compounds as dual antimalarials with multiple targets (i.e. against heme, GR, γ-
glutamylcysteine synthetase or GST) they deserve further screening and development. 
Another promising drug is methylene blue (MB), which is already in phase II 
clinical trial. This drug has been evaluated in combination with the current 
antimalarials. The combinations MB-artesunate and MB-amodiaquine were compared 
with artesunate-amodiaquine. The MB combinations had significant gametocytocidal 
effect in addition to rapid clearance of asexual parasitemia (Coulibaly et al., 2009). 
Phase-III clinical trials of this drug are expected soon (Olliaro and Wells, 2009). 
Apart from the new compounds under development, most conventional 
antimalarials act through interference with the redox metabolism of the parasite as well 
as that of the RBCs. For the aminoquinolines, inhibition of FP polymerization is part of 
their action mechanism, although they show slight differences in their mode of action 
with respect to FP targeting and GSH metabolism. The inhibition of FP polymerization 
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leads to accumulation of free FP and eventually killing of the parasite in not clearly 
understood mechanisms that involve depletion of GSH. 
1.5.2  Targeting the thioredoxin dependent system 
Knowledge on the thioredoxin systems recently has undergone major 
developments, probably due to improvements in molecular biology tools parallel to 
genome sequencing projects (Lillig and Holmgren, 2007). The role of the thioredoxin 
system in cellular redox control has been well demonstrated. To date only one study 
reported inhibition of thioredoxin reductase (TrxR) by the ellagic acid derivatives, 
flavellagic acid (FEA) and coruleoellagic acid (CEA)  (Sturm et al., 2009a). As more 
knowledge is gained within this class of oxidoreductases, it deserves to direct further 
efforts into characterizing these proteins as possible therapeutic targets. 
1.5.3  Targeting the multidrug resistant transporters 
As discussed in section 1.4, ABC transporters, especially of the ABCC subfamily 
(MRPs), are involved in the transport of drugs and their conjugates. A number of MRPs 
are implicated in multidrug resistance in tumor cells, and some of them have also been 
shown to transport antimalarial drugs (Wu et al., 2005b). It is therefore likely that 
parasitic as well as erythrocytic MRPs are involved in the perceived efflux of 
antimalarial drugs and GSH/GSSG (Atamna and Ginsburg, 1997). PfMRP1 has 
demonstrated its potential as GSH and antimalarial drug transporter (Raj et al., 2009c). 
Further characterization of PfMRPs as drug targets might be a promising strategy. 
Currently there are no known antimalarials that target this group of transporters. 
While strategies are underway to discover new drugs that will specifically target 
the redox systems in malaria, the relative dependency of the parasite on its own systems 
on one hand, and that of the host on the other, is still uncertain (Kanzok et al., 2000;  
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Komaki-Yasuda et al., 2003; Krnajski et al., 2002; Luersen et al., 2000; Yano et al., 
2008). On one hand, P. berghei shows preference for GSH-rich reticulocytes and 
sensitive strains invading these cells develop CQ resistance (Platel et al., 1999). On the 
other hand a strong decrease in GSH levels in the infected RBC and active extrusion of 
GSH from parasite to erythrocyte cytosol has been demonstrated (Atamna and 
Ginsburg, 1997; Luersen et al., 2000). Based on these reports, the dependency of the 
parasite on host redox systems is questionable. Interestingly it has been shown that the 
plasmoredoxin protein which links glutathione with the thioredoxin systems is non-
essential to blood stage P. berghei (Buchholz et al., 2008). Moreover, disruption of P. 
falciparum peroxiredoxin-1, PfTPrx1   (Komaki-Yasuda et al., 2003) and P. berghei 
peroxiredoxin-1, PbPrx1 (Yano et al., 2006) does not have a lethal effect on blood stages, 
but inhibits sporozoites development in the mosquito (Yano et al., 2008). Yet another 
study reported disruption of the γ-glutamylcysteine synthetase to compromise 
sporozoite development in P. berghei parasite (Vega-Rodriguez et al., 2009). Based on 
these observations it is most likely that existence of several antioxidant enzyme systems 
with overlapping substrates has provided redundant activity, which is exploited by 
parasitic organisms to survive in their variable (intracellular) environments. 
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Table 1.2: Examples of compounds reported to exhibit antimalarial activity through 
interaction with the redox systems. Chloroquine represents all other quinolines. 
 
Antimalarial compound  
 
Targeted system/enzyme 
 
Clinical application  
 
    
Quinolines  Heme polymerization, GSH 
depletion 
Most are treatment 
drugs 
 
 
Artemisinin derivatives Several including PfATPase6 
(Vennerstrom et al., 2004) 
 
Treatment drugs  
Methylene blue  
 
Heme polymerization, GSH 
depletion (Coulibaly et al., 2009) 
In phase II clinical trial  
Menadione GR, γ-GCL,  GST (Ahmad and 
Srivastava, 2008) 
 
Pre-clinical testing   
Cibacrone blue  GST (Ahmad and Srivastava, 
2008) 
 
Pre-clinical testing   
Flavellagic acid and 
Coruleoellagic acid  
 
pfGR, pfγ-GCL, pfGST, pfTrxR  
(Sturm et al., 2009a) 
Pre-clinical testing   
m-5  
 
GR (Davioud-Charvet et al., 2001) Pre-clinical testing   
Compounds 34 and 36 
 
GR (Friebolin et al., 2008) 
 
Pre-clinical testing   
T3.5, dual-drug 
(Acridone derivative)  
Heme polymerization and 
enhanced accumulation in FV 
(Kelly et al., 2009) 
Pre-clinical testing   
 
 
1.6 Summary and concluding remarks 
Reverse genetics and functional studies have shed insight on the understanding 
of the redox systems in the malaria parasite as well as in the human host.  Based on this 
knowledge several studies are underway to strategically intervene with the parasitic 
redox metabolism. The data gathered from such studies is expected to ultimately 
provide useful information in designing new antimalarial drugs or improving the 
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currently available chemotherapeutics as well as protection against the rapid 
development of drug resistance. However, the relative dependency of the parasite on its 
antioxidant systems on one hand, and that of the host on the other, is yet to be clearly 
established. This is worth considering when interpreting results obtained by 
interruption of one of these systems. Therefore chemotherapeutic strategies involving 
multiple targets may be more successful than single-target compounds both in terms of 
effectiveness and in circumventing the parasite’s resistance. Simultaneous targeting of 
both the host and parasitic systems may be an option, although careful evaluation is 
required for such broad spectrum targets. 
 
1.7 Research questions and outline of this thesis 
The aim of this thesis is to investigate the role of human glutathione transferase 
polymorphisms in malaria pathology and to clone and characterize putative ABC 
transporters of the P. falciparum parasite. The specific questions addressed are 
elaborated below. 
Malaria infection induces oxidative stress in the host and the pathophysiology of 
malaria is attributed to the increase in oxidative stress. The host cell antioxidant defense 
systems are important in containing the infection and may determine the clinical 
outcome of the infection. In Chapters 2 and 3 by using polymerase chain reaction 
techniques we investigated the role of glutathione transferase (GST) mu, pi, and theta 
plymorphisms in susceptibility to severe malaria in children. Chapter 1 is based on a 
study performed on Cameroonian samples, while Chapter 2 is based on a study 
performed on Tanzanian samples. 
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The P. falciparum genome encodes several ABC transporters. ABC transporters 
may play a central role in the drug resistance mechanisms either by direct efflux of 
antimalarial drugs or GSH conjugated drugs. Furthermore, ABC transporters of the 
MRP subfamily are responsible for efflux of oxidized GSH (GSSG) out of the parasite 
into the host cell possibly for reduction and recycling. Drug resistant parasites have 
increased GSH metabolism, therefore ABC transporters can be good targets for new 
antimalarial drugs. In addition, targeting these transporters may reverse drug 
resistance. However, only few falciparum ABC transporters have been characterized. In 
Chapter 4 we used bioinformatics and phylogenetic analyses to describe the P. 
falciparum ABC transporter family. We further employed immunocytochemistry to 
determine the sub-cellular localization in the asexual stages of the parasite of three ABC 
transporters, two belonging to the ABCC subfamily and one to the ABCB subfamily. 
For functional characterization and in order to predict the substrates and 
substrate analogues for the ABC transporters, heterologous expression is necessary. 
Chapter 5 of this thesis focused on cloning of seven PfABC transporters using the 
gateway cloning system. Attempts to express four of the PfABCs in different 
heterologous systems are described. Finally, in Chapter 6 the findings of this thesis are 
put into a broader perspective in a general discussion. Conclusions are established and 
future perspectives are given.    
 
 
References 
Ahmad,R., Srivastava,A.K., 2007. Purification and biochemical characterization of cytosolic 
glutathione-S-transferase from malarial parasites Plasmodium yoelii. Parasitology Research 100 (3), 
581-588. 
                                                                                                                                                
 Chapter 1 
  
 - 37 - 
Ahmad,R., Srivastava,A.K., 2008. Inhibition of glutathione-S-transferase from Plasmodium yoelii 
by protoporphyrin IX, cibacron blue and menadione: implications and therapeutic benefits. 
Parasitology Research 102 (4), 805-807. 
Allocati,N., Favaloro,B., Masulli,M., Alexeyev,M.F., Di Ilio,C., 2003. Proteus mirabilis 
glutathione S-transferase B1-1 is involved in protective mechanisms against oxidative and chemical 
stresses. Biochemical Journal 373 , 305-311. 
Allocati,N., Federici,L., Masulli,M., Di Ilio,C., 2009. Glutathione transferases in bacteria. Febs 
Journal 276 (1), 58-75. 
Ando,T., Mimura,K., Johansson,C.C., Hanson,M.G., Mougiakakos,D., Larsson,C., da 
Palma,T.M., Sakurai,D., Norell,H., Li,M.L., Nishimura,M.I., Kiessling,R., 2008. 
Transduction with the Antioxidant Enzyme Catalase Protects Human T Cells against Oxidative 
Stress. Journal of Immunology 181 (12), 8382-8390. 
Asikainen,T.M., Huang,T.T., Taskinen,E., Levonen,A.L., Carlson,E., Lapatto,R., 
Epstein,C.J., Raivio,K.O., 2002. Increased sensitivity of homozygous SOD2 mutant mice to 
oxygen toxicity. Free Radical Biology and Medicine 32 (2), 175-186. 
Atamna,H., Ginsburg,H., 1997. The malaria parasite supplies glutathione to its host cell - 
Investigation of glutathione transport and metabolism in human erythrocytes infected with 
Plasmodium falciparum. European Journal of Biochemistry 250 (3), 670-679. 
Bae,S.H., Woo,H.A., Sung,S.H., Lee,H.E., Lee,S.K., Kil,I.S., Rhee,S.G., 2009. Induction of 
Sulfiredoxin via an Nrf2-Dependent Pathway and Hyperoxidation of Peroxiredoxin III in the Lungs 
of Mice Exposed to Hyperoxia. Antioxidants & Redox Signaling 11 (5), 937-948. 
Baniyash,M., 2006. Chronic inflammation, immunosuppression and cancer: New insights and outlook. 
Seminars in Cancer Biology 16 (1), 80-88. 
Bauer,H., Fritz-Wolf,K., Winzer,A., Kuhner,S., Little,S., Yardley,V., Vezin,H., Palfey,B., 
Schirmer,R.H., vioud-Charvet,E., 2006. A fluoro analogue of the menadione derivative 6-[2 '-
(3 '-methyl)-1 ',4 '-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. 
Crystal structure of the alkylated human enzyme. Journal of the American Chemical Society 128 (33), 
10784-10794. 
Becker,K., Kanzok,S.M., Iozef,R., Fischer,M., Schirmer,R.H., Rahlfs,S., 2003a. 
Plasmoredoxin, a novel redox-active protein unique for malarial parasites. European Journal of 
Biochemistry 270 (6), 1057-1064. 
General introduction                                                                                                                      Chapter 1 
 
 - 38 - 
Becker,K., Rahlfs,S., Nickel,C., Schirmer,R.H., 2003b. Glutathione - Functions and metabolism 
in the malarial parasite Plasmodium falciparum. Biological Chemistry 384 (4), 551-566. 
Becker,K., Tilley,L., Vennerstrom,J.L., Roberts,D., Rogerson,S., Ginsburg,H., 2004. 
Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. International 
Journal for Parasitology 34 (2), 163-189. 
Beer,S.M., Taylor,E.R., Brown,S.E., Dahm,C.C., Costa,N.J., Runswick,M.J., Murphy,M.P., 
2004. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial 
membrane thiol proteins - Implications for mitochondrial redox regulation and antioxidant defense. 
Journal of Biological Chemistry 279 (46), 47939-47951. 
Biot,C., Bauer,H., Schirmer,R.H., vioud-Charvet,E., 2004. 5-Substituted tetrazoles as 
bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase 
inhibitors as antimalarials. Journal of Medicinal Chemistry 47 (24), 5972-5983. 
Bosch,H., Schultgens,R.B.H., Wanders,R.J.A., Tager,J.M., 1992. Biochemistry of Peroxisomes. 
Annual Review of Biochemistry 61 . 
Boucher,I.W., McMillan,P.J., Gabrielsen,M., Akerman,S.E., Brannigan,J.A., Schnick,C., 
Brzozowski,A.M., Wilkinson,A.J., Muller,S., 2006. Structural and biochemical 
characterization of a mitochondrial peroxiredoxin from Plasmodium falciparum. Molecular 
Microbiology 61 (4), 948-959. 
Bozdech,Z., Delling,U., Volkman,S.K., Cowman,A.F., Schurr,E., 1996. Cloning and sequence 
analysis of a novel member of the ATP-binding cassette (ABC) protein gene family from Plasmodium 
falciparum. Molecular and Biochemical Parasitology 81 (1), 41-51. 
Bruns,C.M., Hubatsch,I., Ridderstrom,M., Mannervik,B., Tainer,J.A., 1999. Human 
glutathione transferase A4-4 crystal structures and mutagenesis reveal the basis of high catalytic 
efficiency with toxic lipid peroxidation products. Journal of Molecular Biology 288 (3), 427-439. 
Buchholz,K., Rahlfs,S., Schirmer,H., Becker,K., Matuschewski,K., 2008. Depletion of 
Plasmodium berghei Plasmoredoxin Reveals a Non-Essential Role for Life Cycle Progression of the 
Malaria Parasite. PLoS ONE 3 (6). 
Carlsson,L.M., Jonsson,J., Edlund,T., Marklund,S.L., 1995. Mice Lacking Extracellular-
Superoxide Dismutase Are More Sensitive to Hyperoxia. Proceedings of the National Academy of 
Sciences of the United States of America 92 (14), 6264-6268. 
                                                                                                                                                
 Chapter 1 
  
 - 39 - 
Chiang,W.L., Hsieh,Y.S., Yang,S.F., Lu,T.A., Chu,S.C., 2007. Differential expression of 
glutathione-S-transferase isoenzymes in various types of anemia in Taiwan. Clinica Chimica Acta 375 
(1-2), 110-114. 
Collinson,E.J., Grant,C.M., 2003. Role of yeast glutaredoxins as glutathione S-transferases. Journal 
of Biological Chemistry 278 (25), 22492-22497. 
Collinson,E.J., Wheeler,G.L., Garrido,E.O., Avery,A.M., Avery,S.V., Grant,C.M., 2002. The 
yeast glutaredoxins are active as glutathione peroxidases. Journal of Biological Chemistry 277 (19), 
16712-16717. 
Coulibaly,B., Zoungrana,A., Mockenhaupt,F., Schirmer,H., Klose,C., Mansmann,U., 
Meissner,P., Muller,O., 2009. Strong Gametocytocidal Effect of Methylene Blue-Based 
Combination Therapy against Falciparum Malaria: A Randomised Controlled Trial. PLoS ONE 4 (5). 
Das,M., Bickers,D.R., Mukhtar,H., 1984. Plant Phenols As Invitro Inhibitors of Glutathione-S-
Transferase(S). Biochemical and Biophysical Research Communications 120 (2), 427-433. 
Das,M., Singh,S.V., Mukhtar,H., Awasthi,Y.C., 1986. Differential Inhibition of Rat and Human 
Glutathione-S-Transferase Isoenzymes by Plant Phenols. Biochemical and Biophysical Research 
Communications 141 (3), 1170-1176. 
Dassa,E., Bouige,P., 2001. The ABC of ABCs: a phylogenetic and functional classification of ABC 
systems in living organisms. Research in Microbiology 152 (3-4), 211-229. 
Davioud-Charvet,E., Delarue,S., Biot,C., Schwobel,B., Boehme,C.C., Mussigbrodt,A., 
Maes,L., Sergheraert,C., Grellier,P., Schirmer,R.H., Becker,K., 2001. A prodrug form of a 
Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline. 
Journal of Medicinal Chemistry 44 (24), 4268-4276. 
Dean,M., Annilo,T., 2005. Evolution of the ATP-binding cassette (ABC) transporter superfamily in 
vertebrates. Annual Review of Genomics and Human Genetics 6 , 123-142. 
Dean,M., Rzhetsky,A., Allikmets,R., 2001. The human ATP-binding cassette (ABC) transporter 
superfamily. Genome Research 11 (7), 1156-1166. 
Deponte,M., Becker,K., Rahlfs,S., 2005. Plasmodium falciparum glutaredoxin-like proteins. 
Biological Chemistry 386 (1), 33-40. 
Dondorp,A.M., Angus,B.J., Chotivanich,K., Silamut,K., Ruangveerayuth,R., 
Hardeman,M.R., Kager,P.A., Vreeken,J., White,N.J., 1999. Red blood cell deformability as 
General introduction                                                                                                                      Chapter 1 
 
 - 40 - 
a predictor of anemia in severe falciparum malaria. American Journal of Tropical Medicine and 
Hygiene 60 (5), 733-737. 
Dondorp,A.M., Pongponratn,E., White,N.J., 2004. Reduced microcirculatory flow in severe 
falciparum malaria: pathophysiology and electron-microscopic pathology. Acta Tropica 89 (3), 309-
317. 
Dubois,V.L., Platel,D.F.N., Pauly,G., Tribouleyduret,J., 1995. Plasmodium-Berghei - Implication 
of Intracellular Glutathione and Its Related Enzyme in Chloroquine Resistance In-Vivo. 
Experimental Parasitology 81 (1), 117-124. 
Egan,T.J., Combrinck,J.M., Egan,J., Hearne,G.R., Marques,H.M., Ntenteni,S., Sewell,B.T., 
Smith,P.J., Taylor,D., van Schalkwyk,D.A., Walden,J.C., 2002. Fate of haem iron in the 
malaria parasite Plasmodium falciparum. Biochemical Journal 365 , 343-347. 
Famin,O., Ginsburg,H., 2002. Differential effects of 4-aminoquinoline-containing antimalarial drugs 
on hemoglobin digestion in Plasmodium falciparum-infected erythrocytes. Biochemical 
Pharmacology 63 (3), 393-398. 
Famin,O., Krugliak,M., Ginsburg,H., 1999. Kinetics of inhibition of glutathione-mediated 
degradation of ferriprotoporphyrin IX by antimalarial drugs. Biochemical Pharmacology 58 (1), 59-
68. 
Fisher,A.B., Dodia,C., Manevich,Y., Chen,J.W., Feinstein,S.I., 1999. Phospholipid 
hydroperoxidase are substrates for non-selenium glutathione peroxidase. Journal of Biological 
Chemistry 274 (30), 21326-21334. 
Fitch,C.D., Chevli,R., Banyal,H.S., Phillips,G., Pfaller,M.A., Krogstad,D.J., 1982. Lysis of 
Plasmodium falciparum by Ferriprotoporphyrin-Ix and A Chloroquine-Ferriprotoporphyrin-Ix 
Complex. Antimicrobial Agents and Chemotherapy 21 (5), 819-822. 
Flohe,L., Loschen,G., Eichele,E., Gunzler,W.A., 1972. Glutathione Peroxidase .5. Kinetic 
Mechanism. Hoppe-Seylers Zeitschrift fur Physiologische Chemie 353 (6), 987-&. 
Foley,M., Tilley,L., 1997. Quinoline antimalarials: Mechanisms of action and resistance. International 
Journal for Parasitology 27 (2), 231-240. 
Francis,S.E., Sullivan,D.J., Goldberg,D.E., 1997. Hemoglobin metabolism in the malaria parasite 
Plasmodium falciparum. Annual Review of Microbiology 51 , 97-123. 
                                                                                                                                                
 Chapter 1 
  
 - 41 - 
Fridovich,I., 1995. Superoxide Radical and Superoxide Dismutases. Annual Review of Biochemistry 64 
, 97-112. 
Fridovich,I., 1997. Superoxide anion radical (O-2 radical anion), superoxide dismutases, and related 
matters. Journal of Biological Chemistry 272 (30), 18515-18517. 
Friebolin,W., Jannack,B., Wenzel,N., Furrer,J., Oeser,T., Sanchez,C.P., Lanzer,M., 
Yardley,V., Becker,K., vioud-Charvet,E., 2008. Antimalarial dual drugs based on potent 
inhibitors of glutathione reductase from Plasmodium falciparum. Journal of Medicinal Chemistry 51 
(5), 1260-1277. 
Friedman,J.S., Rebel,V.I., Derby,R., Bell,K., Huang,T.T., Kuypers,F.A., Epstein,C.J., 
Burakoff,S.J., 2001. Absence of mitochondrial superoxide dismutase results in a murine 
hemolytic anemia responsive to therapy with a catalytic antioxidant. Journal of Experimental 
Medicine 193 (8), 925-934. 
Frova,C., 2006. Glutathione transferases in the genomics era: New insights and perspectives. 
Biomolecular Engineering 23 (4), 149-169. 
Ginsburg,H., Famin,O., Zhang,J.M., Krugliak,M., 1998. Inhibition of glutathione-dependent 
degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode 
of action. Biochemical Pharmacology 56 (10), 1305-1313. 
Harvey,J.W., Beutler,E., 1982. Binding of Heme by Glutathione S-Transferase - A Possible Role of 
the Erythrocyte Enzyme. Blood 60 (5), 1227-1231. 
Harwaldt,P., Rahlfs,S., Becker,K., 2002. Glutathione S-transferase of the malarial parasite 
Plasmodium falciparum: Characterization of a potential drug target. Biological Chemistry 383 (5), 
821-830. 
Hashemy,S.I., Holmgren,A., 2008. Regulation of the catalytic activity and structure of human 
thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. Journal of Biological Chemistry 
283 (32), 21890-21898. 
Hayes,J.D., Flanagan,J.U., Jowsey,I.R., 2005. Glutathione transferases. Annual Review of 
Pharmacology and Toxicology 45 , 51-88. 
Hiller,N., Fritz-Wolf,K., Deponte,M., Wende,W., Zimmermann,H., Becker,K., 2006. 
Plasmodium falciparum glutathione S-transferase - Structural and mechanistic studies on ligand 
binding and enzyme inhibition. Protein Science 15 (2), 281-289. 
General introduction                                                                                                                      Chapter 1 
 
 - 42 - 
Ho,Y.S., Magnenat,J.L., Bronson,R.T., Cao,J., Gargano,M., Sugawara,M., Funk,C.D., 1997. 
Mice deficient in cellular glutathione peroxidase develop normally and show no increased sensitivity 
to hyperoxia. Journal of Biological Chemistry 272 (26), 16644-16651. 
Ho,Y.S., Xiong,Y., Ma,W.C., Spector,A., Ho,D.S., 2004. Mice lacking catalase develop normally 
but show differential sensitivity to oxidant tissue injury. Journal of Biological Chemistry 279 (31), 
32804-32812. 
Hunt,N.H., Stocker,R., 1990. Oxidative Stress and the Redox Status of Malaria-Infected Erythrocytes. 
Blood Cells 16 (2-3), 499-526. 
Hyde,S.C., Emsley,P., Hartshorn,M.J., Mimmack,M.M., Gileadi,U., Pearce,S.R., 
Gallagher,M.P., Gill,D.R., Hubbard,R.E., Higgins,C.F., 1990. Structural Model of Atp-
Binding Proteins Associated with Cystic-Fibrosis, Multidrug Resistance and Bacterial Transport. 
Nature 346 (6282), 362-365. 
Iwahara,S., Satoh,H., Song,D.X., Webb,J., Burlingame,A.L., Nagae,Y., Mullereberhard,U., 
1995. Purification, Characterization, and Cloning of A Heme-Binding Protein (23 Kda) in Rat-Liver 
Cytosol. Biochemistry 34 (41), 13398-13406. 
Jakobsson,P.J., Morgenstern,R., Mancini,J., Ford-Hutchinson,A., Persson,B., 1999. 
Common structural features of MAPEG - A widespread superfamily of membrane associated proteins 
with highly divergent functions in eicosanoid and glutathione metabolism. Protein Science 8 (3), 
689-692. 
Janney,S.K., Joist,J.H., Fitch,C.D., 1986. Excess Release of Ferriheme in G6Pd-Deficient 
Erythrocytes - Possible Cause of Hemolysis and Resistance to Malaria. Blood 67 (2), 331-333. 
Johnson,R.M., Goyette,G., Ravindranath,Y., Ho,Y.S., 2000. Red cells from glutathione 
peroxidase-1-deficient mice have nearly normal defenses against exogenous peroxides. Blood 96 (5), 
1985-1988. 
Kamada,K., Goto,S., Okunaga,T., Ihara,Y., Tsuji,K., Kawai,Y., Uchida,K., Osawa,T., 
Matsuo,T., Nagata,I., Kondo,T., 2004. Nuclear glutathione S-transferase pi prevents apoptosis 
by reducing the oxidative stress-induced formation of exocyclic DNA products. Free Radical Biology 
and Medicine 37 (11), 1875-1884. 
Kanai,T., Takahashi,K., Inoue,H., 2006. Three distinct-type glutathione S-transferases from 
Escherichia coli important for defense against oxidative stress. Journal of Biochemistry 140 (5), 703-
711. 
                                                                                                                                                
 Chapter 1 
  
 - 43 - 
Kanzok,S.M., Schirmer,R.H., Turbachova,I., Iozef,R., Becker,K., 2000. The thioredoxin 
system of the malaria parasite Plasmodium falciparum - Glutathione reduction revisited. Journal of 
Biological Chemistry 275 (51), 40180-40186. 
Kawazu,S., Komaki,K., Tsuji,N., Kawai,S., Ikenoue,N., Hatabu,T., Ishikawa,H., 
Matsumoto,Y., Himeno,K., Kano,S., 2001. Molecular characterization of a 2-Cys peroxiredoxin 
from the human malaria parasite Plasmodium falciparum. Molecular and Biochemical Parasitology 
116 (1), 73-79. 
Kawazu,S., Tsuji,N., Hatabu,T., Kawai,S., Matsumoto,Y., Kano,S., 2000. Molecular cloning 
and characterization of a peroxiredoxin from the human malaria parasite Plasmodium falciparum. 
Molecular and Biochemical Parasitology 109 (2), 165-169. 
Kawazu,S.I., Komaki-Yasuda,K., Oku,H., Kano,S., 2008. Peroxiredoxins in malaria parasites: 
Parasitologic aspects. Parasitology International 57 (1), 1-7. 
Kelly,J., Smilkstein,M., Brun,R., Wittlin,S., Cooper,R.A., Lane,K., Janowsky,A., 
Johnson,R.A., Dodean,R.A., Winter,R., Hinrichs,D.J., Riscoe,M.K., 2009. Discivery of 
dual function acridones as a new antimalarial chemotype. Nature 459 , 270-273. 
Kiessling,R., Wasserman,K., Horiguchi,S., Kono,K., Sjoberg,J., Pisa,P., Petersson,M., 
1999. Tumor-induced immune dysfunction. Cancer Immunology Immunotherapy 48 (7), 353-362. 
Klokouzas,A., Shahi,S., Hladky,S.B., Barrand,M.A., van Veen,H.W., 2003. ABC transporters 
and drug resistance in parasitic protozoa. International Journal of Antimicrobial Agents 22 (3), 301-
317. 
Klokouzas,A., Tiffert,T., van Schalkwyk,D., Wu,C.P., van Veen,H.W., Barrand,M.A., 
Hladky,S.B., 2004. Plasmodium falciparum expresses a multidrug resistance-associated protein. 
Biochemical and Biophysical Research Communications 321 (1), 197-201. 
Komaki-Yasuda,K., Kawazu,S., Kano,S., 2003. Disruption of the Plasmodium falciparum 2-Cys 
peroxiredoxin gene renders parasites hypersensitive to reactive oxygen and nitrogen species. Febs 
Letters 547 (1-3), 140-144. 
Krnajski,Z., Gilberger,T.W., Walter,R.D., Cowman,A.F., Muller,S., 2002. Thioredoxin 
reductase is essential for the survival of Plasmodium falciparum erythrocytic stages. Journal of 
Biological Chemistry 277 (29), 25970-25975. 
General introduction                                                                                                                      Chapter 1 
 
 - 44 - 
Krnajski,Z., Walter,R.D., Muller,S., 2001. Isolation and functional analysis of two thioredoxin 
peroxidases (peroxiredoxins) from Plasmodium falciparum. Molecular and Biochemical Parasitology 
113 (2), 303-308. 
Liebau,E., Bergmann,B., Campbell,A.M., Teesdale-Spittle,P., Brophy,P.M., Luersen,K., 
Walter,R.D., 2002. The glutathione S-transferase from Plasmodium falciparum. Molecular and 
Biochemical Parasitology 124 (1-2), 85-90. 
Lillig,C.H., Holmgren,A., 2007. Thioredoxin and related molecules - From biology to health and 
disease. Antioxidants & Redox Signaling 9 (1), 25-47. 
Lonn,M.E., Hudemann,C., Berndt,C., Cherkasov,V., Capani,F., Holmgren,A., Lillig,C.H., 
2008. Expression pattern of human glutaredoxin 2 isoforms: Identification and characterization of 
two testis/cancer cell-specific isoforms. Antioxidants & Redox Signaling 10 (3), 547-557. 
Lu,J., Holmgren,A., 2009. Selenoproteins. Journal of Biological Chemistry 284 (2), 723-727. 
Luersen,K., Walter,R.D., Muller,S., 2000. Plasmodium falciparum-infected red blood cells depend 
on a functional glutathione de novo synthesis attributable to an enhanced loss of glutathione. 
Biochemical Journal 346 , 545-552. 
Makino,N., Mochizuki,Y., Bannai,S., Sugita,Y., 1994. Kinetic-Studies on the Removal of 
Extracellular Hydrogen-Peroxide by Cultured Fibroblasts. Journal of Biological Chemistry 269 (2), 
1020-1025. 
Manevich,Y., Feinstein,S.I., Fisher,A.B., 2004. Activation of the antioxidant enzyme 1-CYS 
peroxiredoxin requires glutathionylation mediated by heterodimerization with pi GST. Proceedings 
of the National Academy of Sciences of the United States of America 101 (11), 3780-3785. 
Marsh,K., Forster,D., Waruiru,C., Mwangi,I., Winstanley,M., Marsh,V., Newton,C., 
Winstanley,P., Warn,P., Peshu,N., Pasvol,G., Snow,R., 1995. Indicators of Life-Threatening 
Malaria in African Children. New England Journal of Medicine 332 (21), 1399-1404. 
Masutani,H., Hirota,K., Sasada,T., UedaTaniguchi,Y., Taniguchi,Y., Sono,H., Yodoi,J., 
1996. Transactivation of an inducible anti-oxidative stress protein, human thioredoxin by HTLV-I 
Tax. Immunology Letters 54 (2-3), 67-71. 
Millard,T.P., Fryer,A.A., McGregor,J.M., 2008. A Protective Effect of Glutathione-S-Transferase 
GSTP1(*)Val(105) against Polymorphic Light Eruption. J. Invest Dermatol. 
                                                                                                                                                
 Chapter 1 
  
 - 45 - 
Molyneux,M.E., Taylor,T.E., Wirima,J.J., Borgstein,A., 1989. Clinical-Features and Prognostic 
Indicators in Pediatric Cerebral Malaria - A Study of 131 Comatose Malawian Children. Quarterly 
Journal of Medicine 71 (265), 441-459. 
Muller,F., Lustgarten,M., Jang,Y., Richardson,A., Van Remmen,H., 2007. Trends in oxidative 
aging theories. Free Radical Biology and Medicine 43 (4), 477-503. 
 
Mueller,S., Riedel,H.D., Stremmel,W., 1997a. Determination of catalase activity at physiological 
hydrogen peroxide concentrations. Analytical Biochemistry 245 (1), 55-60. 
Mueller,S., Riedel,H.D., Stremmel,W., 1997b. Direct evidence for catalase as the predominant 
H2O2-removing enzyme in human erythrocytes. Blood 90 (12), 4973-4978. 
Muller,S., 2004. Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. 
Molecular Microbiology 53 (5), 1291-1305. 
Na,B.K., Kang,J.M., Kim,T.S., Sohn,W.M., 2007. Plasmodium vivax: Molecular cloning, 
expression and characterization of glutathione S-transferase. Experimental Parasitology 116 (4), 414-
418. 
Nagaraj,S., Gupta,K., Pisarev,V., Kinarsky,L., Sherman,S., Kang,L., Herber,D.L., 
Schneck,J., Gabrilovich,D.I., 2007. Altered recognition of antigen is a mechanism of CD8(+) T 
cell tolerance in cancer. Nature Medicine 13 (7), 828-835. 
Neumann,C.A., Krause,D.S., Carman,C.V., Das,S., Dubey,D.P., Abraham,J.L., 
Bronson,R.T., Fujiwara,Y., Orkin,S.H., Van Etten,R.A., 2003. Essential role for the 
peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424 (6948), 
561-565. 
Nickel,C., Rahlfs,S., Deponte,M., Koncarevic,S., Becker,K., 2006. Thioredoxin networks in the 
malarial parasite Plasmodium falciparum. Antioxidants & Redox Signaling 8 (7-8), 1227-1239. 
Nickel,C., Trujillo,M., Rahlfs,S., Deponte,M., Radi,R., Becker,K., 2005. Plasmodium 
falciparum 2-Cys peroxiredoxin reacts with plasmoredoxin and peroxynitrite. Biological Chemistry 
386 (11), 1129-1136. 
Nogueira,F., Alves,C., Estolio do Rosario,V., 2008. Plasmodium falciparum multidrug resistance 
protein (MRP) gene expression under chloroquine and mrfloquine challenge. Journal of Cell and 
Animal Biology 2 (1), 10-20. 
General introduction                                                                                                                      Chapter 1 
 
 - 46 - 
Olliaro,P., Wells,T., 2009. The Global Portfolio of New Antimalarial Medicines Under Development. 
Nature 85 (6), 584-595. 
Orjih,A.U., Banyal,H.S., Chevli,R., Fitch,C.D., 1981. Hemin Lyses Malaria Parasites. Science 214 
(4521), 667-669. 
Peskin,A.V., Low,F.M., Paton,L.N., Maghzal,G.J., Hampton,M.B., Winterbourn,C.C., 2007. 
The high reactivity of peroxiredoxin 2 with H2O2 is not reflected in its reaction with other oxidants 
and thiol reagents. Journal of Biological Chemistry 282 (16), 11885-11892. 
Platel,D.F.N., Mangou,F., Tribouley-Duret,J., 1999. Role of glutathione in the detoxification of 
ferriprotoporphyrin IX in chloroquine resistant Plasmodium berghei. Molecular and Biochemical 
Parasitology 98 (2), 215-223. 
Porras,P., Pedrajas,J.R., Martinez-Galisteo,E., Padilla,C.A., Johansson,C., Holmgren,A., 
Barcena,J.A., 2002. Glutaredoxins catalyze the reduction of glutathione by dihydrolipoamide with 
high efficiency. Biochemical and Biophysical Research Communications 295 (5), 1046-1051. 
Postma,N.S., Mommers,E.C., Eling,W.M.C., Zuidema,J., 1996. Oxidative stress in malaria; 
Implications for prevention and therapy. Pharmacy World & Science 18 (4), 121-129. 
Radfar,A., Diez,A., Bautista,J.M., 2008. Chloroquine mediates specific proteome oxidative damage 
across the erythrocytic cycle of resistant Plasmodium falciparum. Free Radical Biology and Medicine 
44 (12), 2034-2042. 
Rahlfs,S., Becker,K., 2001. Thioredoxin peroxidases of the malarial parasite Plasmodium falciparum. 
European Journal of Biochemistry 268 (5), 1404-1409. 
Rahlfs,S., Fischer,M., Becker,K., 2001. Plasmodium falciparum possesses a classical glutaredoxin 
and a second, glutaredoxin-like protein with a PICOT homology domain. Journal of Biological 
Chemistry 276 (40), 37133-37140. 
Rahlfs,S., Schirmer,R.H., Becker,K., 2002. The thioredoxin system of Plasmodium falciparum and 
other parasites. Cellular and Molecular Life Sciences 59 (6), 1024-1041. 
Raj,D.K., Mu,J.B., Jiang,H.Y., Kabat,J., Singh,S., Sullivan,M., Fay,M.P., McCutchan,T.F., 
Su,X.Z., 2009. Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein 
(PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione. Journal of 
Biological Chemistry 284 (12), 7684-7693. 
                                                                                                                                                
 Chapter 1 
  
 - 47 - 
Ridley,R.G., Dorn,A., Vippagunta,S.R., Vennerstrom,J.L., 1997. Haematin (haem) 
polymerization and its inhibition by quinoline antimalarials. Annals of Tropical Medicine and 
Parasitology 91 (5), 559-566. 
Rosenberg,E., Litus,I., Schwarzfuchs,N., Sinay,R., Schlesinger,P., Golenser,J., 
Baumeister,S., Lingelbach,K., Pollack,Y., 2006. pfmdr2 confers heavy metal resistance to 
Plasmodium falciparum. Journal of Biological Chemistry 281 (37), 27039-27045. 
Rubio,J.P., Cowman,A.F., 1994. Plasmodium-Falciparum - the Pfmdr2 Protein Is Not 
Overexpressed in Chloroquine-Resistant Isolates of the Malaria Parasite. Experimental Parasitology 
79 (2), 137-147. 
Salinas,A.E., Wong,M.G., 1999. Glutathione S-transferases - A review. Current Medicinal Chemistry 
6 (4), 279-309. 
Sanchez,C.P., Rotmann,A., Stein,W.D., Lanzer,M., 2008. Polymorphisms within PfMDR1 alter 
the substrate specificity for antimalarial drugs in Plasmodium falciparum. Mol. Microbiol. 
Sarma,G.N., Nickel,C., Rahlfs,S., Fischer,M., Becker,K., Karplus,P.A., 2005. Crystal structure 
of a novel Plasmodium falciparum 1-Cys peroxiredoxin. Journal of Molecular Biology 346 (4), 1021-
1034. 
Schneider,E., Hunke,S., 1998. ATP-binding-cassette (ABC) transport systems: Functional and 
structural aspects of the ATP-hydrolyzing subunits/domains. Fems Microbiology Reviews 22 (1), 1-
20. 
Shau,H.Y., Gupta,R.K., Golub,S.H., 1993. Identification of A Natural-Killer Enhancing Factor 
(Nkef) from Human Erythroid-Cells. Cellular Immunology 147 (1), 1-11. 
Shelton,M.D., Chock,P.B., Mieyal,J.J., 2005. Glutaredoxin: Role in reversible protein S-
glutathionylation and regulation of redox signal transduction and protein translocation. Antioxidants 
& Redox Signaling 7 (3-4), 348-366. 
Sidhu,A.B.S., Uhlemann,A.C., Valderramos,S.G., Valderramos,J.C., Krishna,S., 
Fidock,D.A., 2006. Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens 
susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. Journal of 
Infectious Diseases 194 (4), 528-535. 
Slater,A.F., 1993. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. 
Pharmacology and therapeutics. 57 (2-3), 203-235. 
General introduction                                                                                                                      Chapter 1 
 
 - 48 - 
Sohail,M., Kaul,A., Raziuddin,M., Adak,T., 2007. Decreased glutathione-S-transferase activity: 
Diagnostic and protective role in vivax malaria. Clinical Biochemistry 40 (5-6), 377-382. 
Spyrou,G., Enmark,E., MirandaVizuete,A., Gustafsson,J.A., 1997. Cloning and expression of a 
novel mammalian thioredoxin. Journal of Biological Chemistry 272 (5), 2936-2941. 
Srivastava,P., Puri,S.K., Kamboj,K.K., Pandey,V.C., 1999. Glutathione-S-transferase activity in 
malarial parasites. Tropical Medicine & International Health 4 (4), 251-254. 
Strange,R.C., Jones,P.W., Fryer,A.A., 2000. Glutathione S-transferase: genetics and role in 
toxicology. Toxicology Letters 112-113 , 357-363. 
Sturm,N., Hu,Y., Zimmermann,H., Fritz-Wolf,K., Wittlin,S., Rahlfs,S., Becker,K., 2009a. 
Compounds Structurally Related to Ellagic Acid Show Improved Antiplasmodial Activity. 
Antimicrobial Agents and Chemotherapy 53 (2), 622-630. 
Sturm,N., Jortzik,E., Mailu,B., Koncarevic,S., Deponte,M., Forchhammer,K., Becker,K., 
2009b. Identification of Proteins Targeted by the Thioredoxin Superfamily in Plasmodium 
falciparum. Plos Pathogens 5 (4). 
Sullivan,D.J., Gluzman,I.Y., Russell,D.G., Goldberg,D.E., 1996. On the molecular mechanism of 
chloroquine's antimalarial action. Proceedings of the National Academy of Sciences of the United 
States of America 93 (21), 11865-11870. 
Sun,Q.A., Kirnarsky,L., Sherman,S., Gladyshev,V.N., 2001. Selenoprotein oxidoreductase with 
specificity for thioredoxin and glutathione systems. Proceedings of the National Academy of Sciences 
of the United States of America 98 (7), 3673-3678. 
Tripathi,T., Rahlfs,S., Becker,K., Bhakuni,V., 2008. Structural and stability characteristics of a 
monothiol glutaredoxin: Glutaredoxin-like protein 1 from Plasmodium falciparum. Biochimica et 
Biophysica Acta-Proteins and Proteomics 1784 (6), 946-952. 
Vega-Rodriguez,J., Franke-Fayard,B., Dinglasan,R.R., Janse,C.J., Pastrana-Mena,R., 
Waters,A.P., Coppens,I., Rodriguez-Orengo,J.F., Jacobs-Lorena,M., Serrano,A.E., 
2009. The Glutathione Biosynthetic Pathway of Plasmodium Is Essential for Mosquito 
Transmission. Plos Pathogens 5 (2). 
Vennerstrom,J.L., Arbe-Barnes,S., Brun,R., Charman,S.A., Chiu,F.C., Chollet,J., Dong,Y., 
Dorn,A., Hunziker,D., Matile,H., McIntosh,K., Padmanilayam,M., Tomas,J.S., 
Scheurer,C., Scorneaux,B., Tang,T., Urwyler,H., Wittlin,S., Charman,W.N., 2004. 
                                                                                                                                                
 Chapter 1 
  
 - 49 - 
Identification of an antimalarial synthetic trioxolane drug development candidate. Nature 430 , 900-
904. 
Walker,J.E., Saraste,M., Runswick,M.J., Gay,N.J., 1982. Distantly Related Sequences in the 
Alpha-Subunits and Beta-Subunits of Atp Synthase, Myosin, Kinases and Other Atp-Requiring 
Enzymes and A Common Nucleotide Binding Fold. Embo Journal 1 (8), 945-951. 
Wang,L.H., Groves,M.J., Hepburn,M.D., Bowen,D.T., 2000. Glutathione S-transferase enzyme 
expression in hematopoietic cell lines implies a differential protective role for T1 and A1 isoenzymes 
in erythroid and for M1 in lymphoid lineages. Haematologica 85 (6), 573-579. 
Wang,Y., Feinstein,S.I., Fisher,A.B., 2008. Peroxiredoxin 6 as an antioxidant enzyme: Protection 
of lung alveolar epithelial type II cells from H2O2-induced oxidative stress. Journal of Cellular 
Biochemistry 104 (4), 1274-1285. 
Wang,Y., Feinstein,S.I., Manevich,Y., Ho,Y.S., Fisher,A.B., 2004. Lung injury and mortality 
with hyperoxia are increased in peroxiredoxin 6 gene-targeted mice. Free Radical Biology and 
Medicine 37 (11), 1736-1743. 
Wang,Y., Feinstein,S.I., Manevich,Y., Ho,Y.S., Fisher,A.B., 2006. Peroxiredoxin 6 gene-
targeted mice show increased lung injury with paraquat-induced oxidative stress. Antioxidants & 
Redox Signaling 8 (1-2), 229-237. 
WHO, 2008. Malaria Report: Estimated burden of malaria in 2006. In: World Health Organization. 
Wu,C.P., Klokouzas,A., Hladky,S.B., Ambudkar,S.V., Barrand,M.A., 2005. Interactions of 
mefloquine with ABC proteins, MRP1 (ABCC1) and MRP4 (ABCC4) that are present in human red 
cell membranes. Biochemical Pharmacology 70 (4), 500-510. 
Xia,C.L., Hu,J.T., Ketterer,B., Taylor,J.B., 1996. The organization of the human GSTP1-1 gene 
promoter and its response to retinoic acid and cellular redox status. Biochemical Journal 313 , 155-
161. 
Yano,K., Komaki-Yasuda,K., Tsuboi,T., Torii,M., Kana,S., Kawazu,S., 2006. 2-Cys 
peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. Molecular and 
Biochemical Parasitology 148 (1), 44-51. 
Yano,K., Otsuki,H., Arai,M., Komaki-Yasuda,K., Tsuboi,T., Torii,M., Kano,S., Kawazu,S.I., 
2008. Disruption of the Plasmodium berghei 2-Cys peroxiredoxin TPx-1 gene hinders the 
General introduction                                                                                                                      Chapter 1 
 
 - 50 - 
sporozoite development in the vector mosquito. Molecular and Biochemical Parasitology 159 (2), 
142-145. 
Ye,Z., Song,H., 2005. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the 
risk of acute leukaemia: A systematic review and meta-analysis. Eur. J. Cancer 41 (7), 980-989. 
Zhang,J.M., Krugliak,M., Ginsburg,H., 1999. The fate of ferriprotorphyrin IX in malaria infected 
erythrocytes in conjunction with the mode of action of antimalarial drugs. Molecular and 
Biochemical Parasitology 99 (1), 129-141. 
Zhao,T.J., Singhal,S.S., Piper,J.T., Cheng,J.Z., Pandya,U., Clark-Wronski,J., Awasthi,S., 
Avasthi,Y.C., 1999. The role of human glutathione S-transferases hGSTA1-1 and hGSTA2-2 in 
protection against oxidative stress. Archives of Biochemistry and Biophysics 367 (2), 216-224. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2 
 
 
 
 
 
 
SEVERE PLASMODIUM FALCIPARUM MALARIA IN 
CAMEROON: ASSOCIATED WITH THE GLUTATHIONE S-
TRANSFERASE M1-NULL GENOTYPE 
Reginald A. Kavishe, Jan B. Koenderink, Mathew B.B. McCall,  
Wilbert H.M.Peters, Bert Mulder, Corneus C. Hermsen, Robert W. Sauerwein,  
Frans G.M. Russel, Andre J.A.M. van der Ven 
 
American Journal of Tropical Medicine and Hygiene 2006; 75(5):827-9 
 
 
 
 
  
 
 
 
   Chapter 2 
 
 
- 53 - 
Summary  
Glutathione S-transferases (GST) are a family of enzymes involved in phase-II 
detoxification of endogenous and xenobiotic compounds. Polymorphisms in GST genes 
have been associated with susceptibility to different diseases. In this study we 
determined the frequencies of polymorphisms in GSTM1, GSTT1, and GSTP1 in DNA of 
138 children from Cameroon, presenting with uncomplicated malaria (N=19), malaria 
with minor complications (N=81), or severe malaria (N=38). Analyses of GSTM1 and 
GSTT1 were performed using PCR-multiplex procedure, while GSTP1 was done by PCR-
RFLP. Subjects presenting with malaria with complications were found more often of 
the GSTM1-null genotype (58–64%) as compared with those with uncomplicated 
malaria (32%), a difference that was statistically significant. We conclude that the 
GSTM1-null genotype is associated with malaria with complications. 
 
2.1 Background  
In severe malaria, release of oxygen free radicals and a variety of pro-
inflammatory cytokines can lead to increased vascular permeability, leakage of colloid 
from intravascular space, pathologic vasodilatation, and myocardial depression with 
ultimate hypovolemia and impaired organ perfusion. In children with malaria, lipid 
peroxidation in both blood plasma and the erythrocytes is increased, while erythrocytic 
antioxidants such as glutathione (GSH), catalase, and tocopherol were shown to be 
lower in patients with malaria than in control subjects (Becker et al., 2004). The 
intracellular parasite digests hemoglobin, thereby releasing free ferroprotoporphyrin or 
heme, which in the presence of oxygen oxidizes to ferriprotoporphyrin or hemin. This 
GST polymorphisms and severe malaria in Cameroon                          Chapter 2 
 
 
- 54 - 
process produces superoxide, which decomposes into H2O2 and O2. Under normal 
conditions heme is polymerized into less toxic hemozoin or malaria pigment. 
Antimalarials like chloroquine and amodiaquine inhibit this reaction, thus building up a 
toxic concentration of ferro/ferriprotoporphyrin (FP) leading to parasite death (Deharo 
et al., 2003; Mukanganyama et al., 2002). Indeed, several studies have suggested that 
an increase in oxidative stress in parasitized red blood cells (RBCs) offers an advantage 
to parasite clearance rather than exacerbating the pathology (Abdulhadi, 2003; Deharo 
et al., 2003; Mukanganyama et al., 2002). Glucose-6-phosphate dehydrogenase 
(G6PD)-deficient individuals for instance, are partially protected against malaria. G6PD 
is essential for NADPH production, which reduces oxidized glutathione.  
Glutathione as an antioxidant is required for growth of the parasite (Deharo et 
al., 2003; Ferreira et al., 2004) but also for maintenance of the redox state of the host 
cell. Altered redox metabolism of the host cells, particularly the endothelial cells, may 
exacerbate disease complications, for example by enhancing endothelial damage, brain 
inflammation, and development of cerebral malaria. Several studies documented escape 
of FP from the parasite’s food vacuole with consequent damage to erythrocyte 
membrane through oxidation of proteins and lipids with eventual lysis of the host cell 
(Schwarzer et al., 1993; Schwarzer and Arese, 1996; Taramelli et al., 1995). To maintain 
the integrity of the erythrocyte membrane, an efficient redox system is required. A 
number of mechanisms are involved in the removal of reactive oxygen species and 
maintenance of cellular redox state, among which are the glutathione S-transferases 
(GSTs).  
GSTs are intracellular proteins that detoxify electrophilic compounds of 
endogenous and exogenous origin by conjugating them with GSH, predisposing them to 
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export out of the cell by multi-drug resistance proteins. In addition GSTs are also known 
to exhibit glutathione peroxidase activity. Human GSTs comprise a family of proteins, 
classified into 4 major classes: GST-alpha (GSTA), GST-mu (GSTM), GSTtheta (GSTT), 
and GST-pi (GSTP). Many studies in both humans and laboratory animals have 
documented strong associations between impaired or deficient GST activity and various 
diseases connected to oxidative stress injury. Such diseases include lung cancer, acute 
leukemia, and many others (Wikman et al., 1999; Ye and Song, 2005; Strange et al., 
1998). However, there is no documented study on the association between genetic 
polymorphisms in GSTs associated with loss of GST enzyme activities and malaria. 
Since malaria pathology progresses with increasing oxidative stress, in this study we 
tested the hypothesis that impaired GST activity would increase severity of malaria 
pathology. We investigated the role of polymorphisms in GSTM, GSTT, and GSTP in 
susceptibility to severe malaria. 
 
2.2 Methods 
DNA of 138 hospitalized children with mild, severe, and very severe malaria, 
which was collected in Yaoundé, Cameroon at the Department of Pediatrics of the 
Central Hospital and in the outpatient clinic of the Messa Dispensary, was used in this 
study. The patients studied were enrolled between February 1994 and October 1996 
(Hermsen et al., 2003).   
Blood of children with symptomatic clinical malaria according to World Health 
Organization (WHO) standards, aged between 8 months and 14 years attending the 
outpatient clinic or admitted to the Central Hospital of Yaoundé, was collected after 
informed consent was obtained. Children with clinical malaria were admitted to the 
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emergency room of the Department of Pediatrics and were examined by the clinical 
staff. All children underwent a complete physical examination and a thick smear was 
made. Then the severity of malaria was assessed according to WHO standards as 
mild/uncomplicated and severe malaria. The severe malaria group was sub-divided into 
severe and very severe. Patients with coma (Blantyre score< 3 (Molyneux et al., 1989), N 
= 30), respiratory distress ((Marsh et al., 1995), N = 9), repeated convulsions (> 1, N = 
10), and/or severe anemia (Hb < 5 g/dL, N = 1) were categorized as very severe, whereas 
those only suffering from impaired consciousness (Blantyre 3–4, N = 72), 
hyperparasitemia (> 5%, N = 1) and/or hyperpyrexia (> 40°C, N = 18) were categorized 
as severe cases. The number of patients categorized in the groups of 
mild/uncomplicated, severe, and very severe malaria was 19 (average age 5.0; 10 female 
and 9 males), 81(average age 4.8; 34 females, 44 males and 3 not recorded) and 38 
(average age 3.5; 16 females, 20 males and 2 not recorded), respectively.  
For GSTM1 and GSTT1 null polymorphisms, no gene products are detected. For 
GSTM1, primers were used as described previously (Brockmoller et al., 1993) Beta-
globin primers were included in the reaction mixture as an internal positive control. A 
650-bp PCR product was expected for GSTM1 and absence of this fragment indicated 2 
null alleles. For GSTT1, primers and methods were used following description by 
Pemble et al. (Pemble et al., 1994), yielding a 480-bp fragment, absence of which 
indicated the null genotype. The PCR was repeated for negative samples to confirm the 
results. Three GSTP1 genotypes occur, resulting from a single point mutation that 
changes Ile-105 to Val, yielding wild-type, heterozygous, and homozygous mutant 
genotypes. The heterozygous form has reduced enzyme activity while the homozygous 
mutant enzyme showed even lower activity (van Lieshout et al., 1999). The 
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polymorphism detection is based on an Alw261 PCR-RFLP and PCR primers were 
designed as described by Watson et al. (Watson et al., 1998).  
 
2.3 Results  
Results of the GST genotyping are depicted in Table 2.1. Overall, 42% of the 
patients were of the GSTM1 (+) genotype, while 58% possessed the GSTM1-null (−) 
genotype. For GSTT1, 64% of the patients possessed a functioning allele (GSTT1 (+) 
while 36% had the GSTT1-null (−) genotype. For GSTP1, 31% of the samples were of the 
homozygous wild-type genotype, 46% heterozygous, and 23% of the homozygous 
mutant genotype. There was a significant difference in the distribution of the GSTM1-
null genotypes between uncomplicated patients and those with malaria with minor 
complications and severe malaria (χ2=6.7, P =0.005; χ2=3.5, P=0.031). The GSTT1 
genotype in uncomplicated malaria and malaria with minor complications was just 
significantly different (χ2= 2.9, P = 0.045), but no significant difference was observed 
for GSTT1 in uncomplicated malaria versus severe malaria (χ2 =0.4, P= 0.26). Also in 
the GSTP1 polymorphisms no significant differences were detected. This study does not 
show any interaction between the GST polymorphisms and the different malaria groups.  
 
Table 2.1: Distribution of GST genotypes among malarial groups  
 
 GSTM1  GSTT1  GSTP1 
 (+) (%) (-) (%)  (+) (%) (-) (%)  WT (%) HT (%) HV (%) 
Total subjects (n=138) 58 (42) 80 (58)  89 (64) 49 (36)  42 (31) 64 (46) 32 (23) 
Uncomplicated (n=19) 13 (68) 6 (32)  15 (79) 4 (21)  4 (21) 11 (58) 4 (21) 
Minor complications (n=81) 26 (36) 52 (64)  47 (58) 34 (42)  28 (35) 35 (43) 18 (22) 
Severe (n=38) 16 (42) 22 (58)  27 (71) 11 (29)  10 (26) 18 (48) 10 (26) 
WT = homozygous wild type, HT = heterozygous, HV = homozygous variant 
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2.4 Discussion  
These findings indicate that subjects lacking the GSTM1 enzyme are significantly 
over-represented in the malaria with minor complications/severe malaria groups as 
compared with the uncomplicated falciparum malaria group, thus supporting our 
hypothesis of involvement of GSTs in malaria pathogenesis. Because GSTM1 catalyzes 
conjugation of GSH to a wide range of electrophiles, we suggest that GSTM1 is 
important for prevention of malaria with minor complications by reduction of oxidative 
stress in malaria. Increase in oxidative stress within the food vacuole of Plasmodium 
berghei helps to kill this parasite as has been demonstrated by the action of chloroquine 
and amodiaquine (Platel et al., 1999). On the other hand, oxidative stress may increase 
oxidative damage of erythrocyte membranes, reducing the deformability of the cells and 
ultimately inducing removal and massive destruction of erythrocytes by macrophages, 
leading to increase in severe anemia, occlusion of peripheral microvasculature, cerebral 
pathology (hypoxia), and cardiac injury observed in severe falciparum malaria. In a 
future study the need for measuring the allele frequency in a control group is necessary. 
When comparing the general distribution of the GSTM1 null genotypes in our patient 
group, however, with the documented distribution in African populations, the 
percentage of GSTM1-null is very high (58%). Other studies document 22–38% of 
GSTM1-null individuals (Mukanganyama et al., 1997; Rossini et al., 2002; Tiemersma et 
al., 2001), which is in line with our results in the uncomplicated malaria group (32%), 
indicating that individuals with the null phenotype might be more likely hospitalized 
when suffering from malaria. In Caucasians, however, GSTM1 is lacking in 50–63% of 
the population (Mukanganyama et al., 1997; Tiemersma et al., 2001).  
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2.5 Conclusions  
In conclusion, we found an association between the GSTM1-null genotype and 
malaria with minor complications/severe malaria. It is important to perform additional 
large studies in Africa, to further investigate the connection of GSTs and malaria.  
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Summary  
Malaria infection induces oxidative stress in the host cells. Antioxidant enzymes 
like glutathione S-transferases (GSTs) are responsible for fighting reactive oxygen 
species and reduction of oxidative stress. Common GST polymorphisms have been 
associated with susceptibility to different diseases whose pathologies involve oxidative 
stress. In this study we tested the hypothesis that GST polymorphisms that lead to 
reduced or lack of enzyme activity are associated with severe P. falciparum malarial 
anemia. We investigated the genotypic distribution of GSTM1, GSTT1, and GSTP1 
polymorphisms between mild malaria (n=107) and severe malarial anemia (n=50) in 
Tanzanian children. We did not find a significant relationship with the GSTT1 
polymorphism. GSTM1-null was higher in severe malaria anemia group but the 
difference was not significant (p=0.08). However, a significant association of GSTP1 
I105V genotype with severe malarial anemia was discovered (26.0% against 10.3% mild 
malaria, p=0.004). We conclude that GSTP1 and possibly GSTM1 may protect against 
severe falciparum malaria in children. 
 
3.1 Background 
Oxidative stress plays an important role in malaria immunity and pathogenesis.  
Malaria-induced oxidative stress is thought to originate from immuno-defensive 
reactions of the host cells against the parasite and as a result of parasite metabolism. 
The parasite feeds on hemoglobin and releases the highly reactive and toxic heme. This 
can react with molecular oxygen to form hemin and superoxide radical (O2-), a highly 
reactive oxygen species. In the parasite’s food vacuole heme is, however, rendered inert 
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and nontoxic through conversion into hemozoin, the malaria pigment (Pagola et al., 
2000). Most of the quinoline antimalarials interfere with the conversion of heme to 
hemozoin thereby inducing its accumulation inside the food vacuole and eventually 
killing the parasite (Slater, 1993; Pandey et al., 2001).  
In severe malaria, parasite toxins may trigger the release of oxygen free radicals 
and stimulate a variety of pro-inflammatory cytokines, such as tumor necrosis factor-
alpha, interleukins, gamma interferon and nitric oxide (Maitland and Marsh, 2004).  
These pro-inflammatory factors are believed to cause much of the clinical complications 
observed in severe malaria with multiple organ involvement. Several studies have 
implicated malaria induced oxidative stress in complications such as reduced 
macrophage function, reduced erythrocyte deformability and increased activation of 
pro-inflammatory cytokines (Schwarzer et al., 1993; Schwarzer and Arese, 1996; 
Taramelli et al., 1995). In children with malaria, both blood plasma and erythrocytic 
lipid peroxidation are increased, while erythrocytic antioxidants such as glutathione 
(GSH) were shown to be lower in patients than in controls (Becker et al., 2004). 
Polymorphisms resulting into absence or reduced enzyme activity have been identified 
and linked with pathogenesis in a number of disorders and diseases characterized with 
increased oxidative stress (AliOsman et al., 1997; Strange et al., 2000; Strange et al., 
1998). In a previous study we observed that GSTM1-null genotype was associated with 
severe malaria in Cameroonian children (Kavishe et al., 2006). In this study we have 
investigated the genotypic distribution of human GSTM1, GSTT1, and GSTP1 
polymorphisms in mild versus severe malaria in Tanzanian children. 
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3.2 Methods 
The clinical data and DNA samples of this study were collected in the period 
between July-September 2006 in a drug efficacy study of mild malaria cases 
(Shekalaghe et al., 2007) in Mnyuzi, Tanga Region, Tanzania. Briefly, children aged 3–
15 years with a temperature >37.5ºC or a history of fever within the last 48 hours and 
with P. falciparum mono-infection at a density between 500–100,000 parasites/µL 
were eligible for recruitment. Children with a hemoglobin (Hb) concentration below 8 
g/dL, as measured by HemoCue, were excluded. Children with severe malaria were 
included for the current study in the same study period. Severe anemia (Hb < 5 g/dL) 
was observed in all children who attended the clinic with severe malaria. Additional 
signs of severe disease that were examined: hyper parasitaemia (≥250,000 
parasites/µl), metabolic acidosis manifested by respiratory distress as described by 
Marsh et al(Marsh et al., 1995), cerebral malaria presented as coma score ≤ 2 (Blantyre 
coma scale)(Molyneux et al., 1989) or impaired consciousness with Blantyre score < 3 
and prostration or extreme weakness (e.g. inability to sit or stand). For severe cases 
treatment was initiated with quinine according to Tanzanian National Guidelines and 
referred to the nearby district hospital in Korogwe in case the study physician 
considered this appropriate. There was no active follow-up of the outcome of severe 
malaria cases after the appropriate treatment was installed. 
For all mild and severe malaria cases, a malaria blood slide, Hb measurement 
and filter paper DNA sample were collected. A short questionnaire was used to obtain 
information on sex, age, disease presentation and ethnicity of the patient. The ethical 
clearance for the collection of the mild malaria material was obtained from the 
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Tanzanian National Institute for Medical Research (NIMR/HQ/R.8a Vol. XIII/446) and 
clearance for the collection of material of severe malaria cases was obtained from 
Kilimanjaro Christian Medical Centre (KCMC 2006#28). In the informed consent 
obtained from the children’s parents or guardians, they approved the use of their 
children’s DNA samples to study the relation between human genetic factors and 
malaria disease presentation. DNA was extracted from the dried filter papers using the 
Nucleospin® Tissues kit (Macherey-Nagel), PCR was performed using native, Taq 
polymerase (invitrogen) and all primers were purchased from Biolegio, Nijmegen, The 
Netherlands. Primers for  GSTT1, GSTM1, and  GSTP1 were designed according to 
Pemble et al.(Pemble et al., 1994), Bröckmoller et al.(Brockmoller et al., 1993), and 
Watson et al.(Watson et al., 1998), respectively. PCR conditions for GSTM1, GSTT1, and 
GSTP1 were followed as previously described (Kavishe et al., 2006). Samples that gave 
negative results for GSTM1 and T1 were measured again with β-globin as a control. 
 
3.3 Results and discussion 
A total of 107 mild and 50 severe malaria cases were enrolled. Parasite density in 
the severe malaria group ranged from 4,640 – 174,000 parasites/µL and was higher 
than in the mild malaria group (Wilcoxon-rank sum test, p<0.001). For more group 
characteristics see Table 3.1. 
The results of the polymorphism analysis in mild and severe malaria are depicted 
in Table 3.2. For GSTM1 there was a higher prevalence of GSTM1-null genotype in 
severe group (40%) than in the mild group (26.2%) although not statistically significant 
(p=0.08). The observed distributions in mild malaria are comparable to the reported 
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distribution of GSTM1-null in African population (22 – 39%) (Mcglynn et al., 1995; 
Mukanganyama et al., 1997; Rossini et al., 2002; Tiemersma et al., 2001; Zhao et al., 
1994). In Caucasian population, however, the GSTM1-null frequency is higher (around 
50%) than in the African population (Rossini et al., 2002; Schneider et al., 2004; Zhao 
et al., 1994).  In our previous study with 138 children from Cameroon, we found a 
statistically significant difference for the GSTM1-null frequency: 32% and 58% in 
uncomplicated malaria and severe malaria, respectively (Kavishe et al., 2006).  
The prevalence of homozygous GSTP1 I105V in the severe malaria group (26.0%) 
was significantly higher than in the mild group (10.3%). This indicates for the first time 
an association of the GSTP1 I105V genotype with severe malaria. There is evidence that 
the GSTP1 I105V polymorphism may have a substrate-dependent effect on the enzyme 
activity (Hu et al., 1997; Sundberg et al., 1998; Watson et al., 1998). The general 
distribution of the homozygous GSTP1 I105V genotype in the mild malaria group is 
comparable to previous studies in a Brazilian population of African descent (8.3%) and 
Caucasians (11.3%)(Rossini et al., 2002; Schneider et al., 2004). In our previous study 
with Cameroonian children(Kavishe et al., 2006) we found in uncomplicated malaria 
(21%) and severe malaria (26%) frequencies that are comparable to what we now 
observe in severe malaria (26.0%).    
When a combined analysis of GSTM1 and GSTP1 was performed, the presence of 
wild type condition on one or both of the two genes was 64.0% and 83.2% for the severe 
and mild malaria groups, respectively, and for the presence of mutations on both 
enzymes (hetero- or homozygous mutant) was 36.0% and 16.8% for the severe and mild 
malaria groups, respectively (p = 0.007). The prevalence of GSTT1-null was comparable 
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in both groups (48% and 54%). In the Cameroonian study we also observed no 
differences; although the frequencies were lower (21% and 29%).  
 
Table 3.1: Characteristics of mild versus severe malaria in falciparum malaria in Tanzanian 
children. 
 Mild  Severe malaria 
N 107 50 
Age, median (IQR) 5.0 (3.0 – 9.0) 8.0 (5.0 – 11.0) 
Gender, % male (n/N) 51.4 (55/107) 60.0 (30/50) 
Hemoglobin concentration, median g/dL 
(IQR) 
10.6 (9.7 – 11.9) 4.3 (3.8 – 4.8) 
Temperature, median (IQR) 37.3 (36.9 – 38.0) 38.5 (37.8 – 39.1) 
Asexual parasite density, GM (IQR) 7,700  
(1,120 – 23,480) 
105,900  
(57,480 – 121,040) 
Signs of severe disease:   
 Severe anemia, % (n/N) - 100.0 (50/50) 
 Respiratory distress, % (n/N) - 6.0 (3/50) 
 Reduced consciousness, % (n/N) - 4.0 (2/50) 
 Prostration, % (n/N) - 8.0 (4/50) 
IQR = interquartile range, GM = group median. 
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This study has shown association of GSTP1 I105V, and a trend but not significant 
association of GSTM1, with severe malaria anemia. GSTP1 and GSTM1 are expressed in 
all blood cells with higher expression in lymphoid than erythroid cell types, whereas 
GSTT1 and GSTA are expressed in higher levels in erythrocytes than in lymphoid cells 
(Wang et al., 2000).  In this study we did not investigate on GSTA and we did not detect 
an association of GSTT1 with malaria, which is consistent with our previous observation 
(Kavishe et al., 2006). It is not clear how GST polymorphisms can affect malaria 
infection outcome. GSH is important for parasite growth and in vitro studies have 
documented detoxification of heme via a GSH-utilizing pathway, that can be inhibited 
by chloroquine and amodiaquine (Famin et al., 1999; Ginsburg et al., 1998). 
Table 3.2: Genotypic and allelic distribution of GSTs gene polymorphisms among mild 
versus severe falciparum malaria groups in tanznian children. 
 Mild  malaria Severe malaria P-value 
GSTM1-null, % (n/N) 26.2 (28/107) 40.0 (20/50) 0.08 
GSTT1-null, % (n/N) 47.7 (51/107) 54.0 (27/50) 0.46 
GSTP1    
 Wild type, % (n/N) 39.3 (42/107) 16.0 (8/50)  
 Heterozygous mutant, % (n/N) 50.5 (54/107) 58.0 (29/50)  
 Homozygous mutant, % (n/N) 10.3 (11/107) 26.0 (13/50) 0.004* 
 
GSTM1 and P1 combined,  
   
  
One or both enzyme wild type, % 
(n/N) 
 
83.2 (89/107) 
 
64.0 (32/50) 
 
 Both enzymes mutant (P1-
hetero/homozygous), % (n/N) 
16.8 (18/107) 36.0 (18/50) 0.007 
* P-value of mutants (combined homo- and heterozygotes) compared to wild type 
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Furthermore, drugs known to reduce cellular GSH were shown to potentiate the action 
of chloroquine in drug-resistant rodent malaria (Deharo et al., 2003).  
GST polymorphisms can change the enzyme activity, which can lead to reduced 
detoxification of the host cell or increased availability of host GSH that might be utilized 
by the parasite. In both cases the malaria pathology could be accelerated. It is also likely 
that the impact of GSTs is not direct on erythrocytes but on other cells that are involved 
in the immune response mechanisms and that severe malarial anemia as an outcome 
can partly be attributed to such responses. Therefore, further studies including in vitro 
cellular studies to assess malarial outcomes for specific GST polymorphism genotypes 
are important. 
 
3.4 Conclusions 
 In conclusion GSTP1 and possibly GSTM1 may have protective effects against 
severe falciparum malaria in children. The contribution of specific GST polymorphisms 
to severe disease may differ between populations or geographical areas. These findings 
do not undermine the importance of oxidative stress in malaria clearance, but rather 
provide a broader perspective on the impact of oxidative stress on both the host and 
parasite cells.  
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Summary 
The spread of drug resistance has been a major obstacle to the control of malaria. 
The mechanisms underlying drug resistance in malaria seem to be complex and 
multigenic. The current literature on multiple drug resistance against anti-malarials has 
documented PfMDR1, an ATP-binding cassette (ABC) protein, as an important 
determinant of resistance. In the Plasmodium falciparum genome, there are several 
ABC transporters some of which could be putative drug transporting proteins. In order 
to understand the molecular mechanisms underlying drug resistance, characterization 
of these transporters is essential. The aim of this study was to characterize and localize 
putative ABC transporters. In the plasmoDB database, 16 members of the P. falciparum 
ABC family can be identified, 11 of which are putative transport proteins. A phylogenetic 
analysis of the aligned NBDs of the PfABC genes was performed. Antibodies against 
PfMRP1 (PfABCC1), PfMRP2 (PfABCC2), and PfMDR5 (PfABCB5) were generated, 
affinity purified and used in immunocytochemistry to localize the proteins in the 
asexual stages of the parasite. The ABC family members of P. falciparum were 
categorized into subfamilies. The ABC B subfamily was the largest and contained seven 
members. Other family members that could be involved in drug transport are PfABCC1, 
PfABCC2, PfABCG1, and PfABCI3. The expression and localization of three ABC 
transport proteins was determined. PfMRP1, PfMRP2, and PfMDR5 are localized to the 
plasma membrane in all asexual stages of the parasite. In conclusion, 11 of the 16 ABC 
proteins in the P. falciparum genome are putative transport proteins, some of which 
might be involved in drug resistance. Moreover, it was demonstrated that three of these 
proteins are expressed on the parasite’s plasma membrane. 
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4.1 Background 
Drug resistance is a major problem in malaria. Today only a limited number of effective 
antimalarials is available. An important reason for therapeutic failure in malaria 
treatment could be that drugs do not reach their target sites, due to active extrusion by 
the parasite. The transport proteins responsible for this type of resistance are so-called 
multidrug resistance proteins (MDR /MRP), most of which belong to the super family of 
ATP binding cassette (ABC) proteins, one of the largest protein families. Many of these 
plasma membrane proteins actively pump out a wide range of structurally and 
functionally diverse amphipathic drugs, thereby decreasing the intracellular drug 
accumulation and resulting in drug resistance (Dassa and Bouige, 2001; Dean et al., 
2001). The structure of a typical ABC transporter consists of six trans-membrane 
segments that form a trans-membrane domain (TMD) and the Walker A and Walker B 
motifs that form a nucleotide binding domain (NBD) (Fig. 4.1).  
 
Figure 4.1: Typical structure of an ABC full transporter 
The TMDs each contain 6 transmembrane (TM) segments and the NBDs contain the Walker A 
and Walker B motifs. ABC half transporters consists of one TMD and one NBD that upon 
translation combine to form a functional unit. 
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ABC transporters are either encoded as full transporters (TMD-NBD-TMD-NBD) 
or as half transporters (TMD-NBD) that upon translation combine to form a functional 
unit. Apart from their normal physiological role, ABC transporters are involved in 
various diseases either by a mutation or through an altered mode of their expression 
(Dean and Annilo, 2005; Klokouzas et al., 2003). Several polymorphisms and an 
increased copy number of the Plasmodium falciparum MDR1 have been associated with 
drug resistance (Valderramos and Fidock, 2006). Heterologous expression data indeed 
show that PfMDR1-mediated anti-malarial drug transport is affected by some of these 
polymorphisms (Lekostaj et al., 2008; Sanchez et al., 2008). The other member of the 
PfABC B family that has been characterized is the half transporter PfMDR2 that confers 
heavy metal resistance to P. falciparum and most likely is not involved in drug 
resistance (Rosenberg et al., 2006). Finally, PfMRP1 polymorphisms have been 
associated with drug resistance and recently it has been shown that PfMRP1 transports 
anti-malarial drugs and glutathione (Raj et al., 2009). PfMDR1 has been detected in the 
membrane of the food vacuole (Cowman et al., 1991), which is in contrast to PfMRP1 
that has been immunolocalized in the plasma membrane of the parasite (Klokouzas et 
al., 2004; Raj et al., 2009). In previous studies the P. falciparum ABC family members 
were identified (Gardner et al., 2002; Martin et al., 2005) and categorized (Gangwar et 
al., 2009; Sauvage et al., 2009). In this study, the P. falciparum ABC transporter family 
has also been categorized and the database sequence of PfMRP1, PfMRP2, and PfMDR5 
was confirmed. Moreover, with immunocytochemistry techniques it was shown that all 
three transporters are probably present in the plasma membrane of the parasite during 
the asexual erythrocytic stages. 
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4.2 Methods 
Parasite culture, extraction and DNA isolation: NF54 (Amsterdam 
airport) strain of P. falciparum was cultured as described by Ponnudurai et al 
(Ponnudurai et al., 1986). The culture medium (Ifediba and Vanderberg, 1980) was 
changed twice daily. Infected blood culture was centrifuged at 1000 g for 5 minutes to 
collect RBCs. After washing twice with PBS the cells were resuspended in 0.05% saponin 
in PBS and incubated at 37oC for 30 minutes. Then the sample was centrifuged at 2000 
g for 10 minutes to collect the parasites. Parasite cells were washed twice with PBS and 
genomic DNA was isolated using the QIAamp DNA mini kit (Qiagen, Venlo, The 
Netherlands) following the cultured cells protocol as directed by the manufacturer. RNA 
was isolated using standard Trizol (guanidinium isothiocyanate) method. Briefly, 500 µl 
Trizol reagent (Invitrogen) was added to the parasite pellet followed with 2.5 µl glycogen 
solution (18 mg/ml), the mixture was homogenized with pipette and incubated on ice 
for 5 min 50 µl chloroform was added and after shaking thoroughly the mixture was 
incubated on ice for 10 min. Centrifugation at 13,000 g for 15 min at 4oC separated the 
mixture into upper aqueous and lower chloroform phases. The aqueous phase which 
contains RNA was transferred into a fresh tube and 240 µl isopropyl alcohol was added, 
mixed by vortex and incubated on ice for 10 min prior to centrifugation at 13,000 g for 
20 min at 4oC. The supernatant was discarded and the RNA pellet was air-dried and 
dissolved in 20 µl DEPC treated water. RNA was stored at -20oC until use. 
Sequencing of PfMRP1, PfMRP2, and PfMDR5: cDNA was synthesized 
with superscript-II reverse transcriptase and oligo-dT primers (Invitrogen). PCR for the 
ABC genes was performed on cDNA using Takara LA Taq. PCR protocol was followed as 
outlined on Takara protocol except that annealing was done at 58oC for 30 sec, 
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extension at 62oC for 10 min, 25 cycles with final extension 72oC for 5 minutes. The PCR 
product was PEG-purified and cloned into pDONR-221 entry-vector using BP clonase 
kit (Invitrogen) following manufacturer’s instructions. Sequencing was performed using 
ABI3730 analyzer (Applied biosystems Inc.). 
Antibodies: PfMRP1 polyclonal antibody was raised in rabbits against the 
specific peptides 215CSNNNHLQNPDAFY228 and 1420YASGIIKLYKEKNYV1434 as 
described previously (Klokouzas et al., 2004) (Eurogentec, Belgium), whereas the 
PfMDR5 polyclonal antibody was designed and produced in rabbits (EZ Biolab, USA) 
against the peptide 730CQSTKYNSQCYQKNK744 in the cytosolic loop of the protein. For 
PfMRP2 a GST-fusion peptide was produced in Escherichia coli using pGEX-3X vector. 
 This peptide corresponds to a 70 amino acid long region within the cytosolic loop of 
PfMRP2 represented by the sequence: LHYEGNLVDYIKKNNIVVKEDIVQTNKQCEKK 
SLTNEQVKSMLSLNEDWNYMHRVKKKSITQKETTKNYD. The peptide was extracted 
and purified from E. coli using glutathione-agarose beads (BD Biosciences). 2 ml of the 
purified peptide was subcutaneously injected into rabbits followed with a 1st and 2nd 
boost on day 21 and 42, respectively. Pre-immune serum was taken on day zero and 
after 63 days serum was collected. For immuno-localization experiments, the polyclonal 
sera for PfMRP1 and PFMDR5 were affinity purified using Sulfolink immobilization kit 
for peptides (Thermo scientific, USA) while for PfMRP2 the Affigel-15 kit (Bio-Rad 
Laboratories) was used as described by the manufacturers. 
Immuno-localization: Infected RBCs were fixed in 4% paraformaldehyde for 
10 minutes at room temperature then washed once with PBS. The cells were applied on 
poly-L-lysine coated slide cover slips (12mm,Menzel GmbH & co KG, Germany) and air 
dried for 5 - 10 minutes. Cover slips were quenched with 0.15% glycine in 0.5% PBS-
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tween20 (PBST) for 10 minutes at room temp followed by washing twice with PBST and 
incubation with 0.1% tritonX100 (BDH chemicals) for 45  minutes at room temp. After 
washing once with PBST, blocking was done with normal goat serum (Zymed, USA) for 1 
hr at room temp followed with washing once with PBST. Cover slips were then 
incubated with primary antibody: rabbit polyclonals and mouse anti-PfERC (MR4, 
MRA-87 Pf39 mouse antiserum, deposited by TJ Templeton) or mouse anti-
glycophorin-A monoclonals (Caltag laboratories, Invitrogen) at 4oC overnight followed 
with three times washing each for 20minutes with PBST at room temperature. The 
secondary antibodies Alexa 594 goat anti-rabbit and Alexa 488 goat anti-mouse 
monoclonals (Molecular probes, The Netherlands) were applied on the cover slips for 2 
hrs at room temperature. After rinsing two times with PBST, the cover slips were 
incubated for 30 minutes with DAPI followed with 2 x 20 minutes washing with PBST at 
room temperature. The cover slips were then briefly air-dried in the dark and mounted 
on microscope slides (Menzel GmbH & co KG, Germany) using Dako fluorescent 
mounting medium (Dako North America Inc., Carpinteria USA). Slides were imaged 
using a confocal microscope (Olympus FV1000). Image J free software version 1.43 was 
used to process images. 
 
4.3 Results 
Identification and characterization of ABC transport proteins. In the 
plasmoDB database, a PFAM (PF00005:ABC_tran ABC transporter) search for ABC 
transport proteins in P. falciparum resulted in 16 hits. PfMDR1 (PFE1150w), 
PfMDR2(PF14_0455), and PfMRP1 (PFA0590w) are hits that have been described in 
literature by several groups (Cowman et al., 1991; Raj et al., 2009; Rosenberg et al., 
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2006), but the other family members have not been the subject of investigation yet. In 
this study it was determined if the family members are full (two NBDs) or half 
transporters (one NBD). Next the NBD (30 amino acids before Walker A until Walker B) 
were aligned with ClustalW2 (Larkin et al., 2007). Part of the aligned sequence with the 
Walker A (GxxGxGKST or [AG]xxxxGK[ST]), the ABC signature sequence (LSGGQ), and 
Walker B (hhhhDEPT orDExxxxxD) are shown in Fig. 4.2.  
 
Figure 4.2: NBD Alignment of P. falciparum ABC superfamily 
The figure shows a part of the with ClustalW2 aligned sequence with Walker A (GxxGxGKST or 
[AG]xxxxGK[ST]), ABC signature sequence (LSGGQ), and Walker B (hhhhDEPT or DExxxxxD). 
X is any amino acid whereas h is a hydrophobic amino acid. 
 
 
The phylogenetic data was imported in TreeView (Page, 1996) and visualized as a 
phylogram in Fig. 4.3. A blast search against human proteins clearly shows that there 
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Figure 4.3: Phylogram of the P. falciparum ABC superfamily 
The NBDs were aligned and the phylogenetic data was imported in TreeView. In combination 
with blast searches the ABC transport proteins were categorized in subfamilies. 
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are no members of the A subfamily. However, P. falciparum contains 11 putative 
transport proteins containing TMDs that belong to the B, C, G and I subfamilies. In 
addition, there are five ABC family members that do not contain a TMD. Three of these 
belong to the E and F subfamilies, whereas the other two members were classified in the 
I subfamily that was introduced for the plant ABC proteins recently (Verrier et al., 
2008). The numbering within each subfamily is shown in Table 4.1 and was done 
according to the existing chronological numbering (PfMDR1, PfMDR2, PfMRP1, and 
PfMRP2). Moreover, neighboring ABC members in the phylogenetic tree obtained 
sequential numbering. The numbers do not carry additional information, such as 
relationship with ABC transporters of other species. The domain organization was 
established by analysis of the sequences with SMART (Letunic et al., 2009). This study 
focuses on PfMRP1 (PFA0590w), PfMRP2 (PFL1410c), and PfMDR5 (PF13_0218), 
because their antibody generation was successful. PfMRP1 and PfMRP2 are both full 
transporters that belong to the ABC C family, whereas PfMDR5 is a half transporter that 
belongs to the ABCB family. For these three transporters, the trans-membrane segments 
were determined with TMHMM (Krogh et al., 2001). Some of the trans-membrane 
segments were not predicted, but weak probabilities of TM helices were assigned as such 
in order to obtain the correct ABC trans-membrane domains with six trans-membrane 
segments (Table 4.2). PfMRP1, PfMRP2, and PfMDR5 genes were sequenced and the 
results matched the published data and no polymorphisms were observed. 
 
 Localization of PfMRP1, PfMRP2, and PfMDR5. Polyclonal antibodies 
were generated by immunization of rabbits with specific peptides for the P. falciparum 
ABC proteins. Blast searches with the peptides showed no relevant specific hits with 
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other proteins. To minimize aspecific binding immuno
peptides were used for immuno
used to stain erythrocyte membranes thus contrasting them from parasite cells while the 
PfERC antibody, which binds to an intracellular calcium binding protein located on the 
endoplasmic reticulum, was used to determine intracellular localization of the pfABC
 
Figure 4.4: Localization of PfMRP1
In column 1 (blue, DAPI) shows the nuclear staining. In column 2 (red) shows PfMRP1 staining.  
In column 3 (green) shows glycophorinA (A, B, and C) or PfERC (D and E) staining. Column 4 
shows the merge of column 1–3. Finally, column  5 shows the 
image. Represented in rows: A, rings; B, early schizont; C, 
and ring. The arrow indicates the food vacuole
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-localization studies. The glycophorin-A antibody was 
 within the asexual stages of P. falciparum
differential interference contrast 
schizont;  D, trophozoite; E, schizont 
.  
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Figure 4.5: Localization of PfMRP2 
In column 1 (blue, DAPI) shows the nuclear staining. In column 2 (red) shows PfMRP2 staining.  
In column 3 (green) shows glycophorin
shows the merge of column 1–3. Finally, column  5 shows the 
image. Represented in rows: 
erythrocyte: trophozoites; C, three trophs (T) and two rings (R)
indicates food vacuole.  
 
PfMRP1 localized to the parasites plasma membrane and no signal was observed on the 
erythrocyte membrane or in the region around the food vacuole. In the differential 
interface contrast image the food vacuole can be recognized from its dark
appearance (presence of hemozoin crystals). These results are consistent with those 
reported in a recent study (Raj et al., 2009) in which plasma membrane localization of 
PfMRP1 was reported also, with possible intracellular expression.
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-A (A and B) or PfERC (C and D) staining. Column 4 
differential interference contrast 
A, multiple infected erythrocyte: rings; B, double infected 
; D, early schizont. Arrow 
 The results in this
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Table 4.1:  The Plasmodium falciparum ABC superfamily 
 
Subfamily 
 
Gene identification  
 
Domain  organization 
 
Amino acids  
ABCB 
    ABCB1 
    ABCB2 
    ABCB3 
    ABCB4 
    ABCB5 
    ABCB6 
    ABCB7 
 
PFE1150w  PfMDR1  
PF14_0455 PfMDR2 
PF11_0466 
PFC0125w 
PF13_0218 
PF13_0271 
PFL0495c 
 
(MSD-NBD)2 
MSD-NBD 
MSD-NBD 
MSD-NBD 
MSD-NBD 
MSD-NBD 
MSD-NBD 
 
1419 
1024 
872 
1365 
925 
1049 
855 
ABCC 
    ABCC1 
    ABCC2 
 
PFA0590w  PfMRP1 
PFL1410c  PfMRP2 
 
(MSD-NBD)2 
(MSD-NBD)2 
 
1822  
2108  
ABCE 
    ABCE1  
 
MAL13 P1.344  
 
 (NBD)2  
 
619  
ABCF       
    ABCF1 
    ABCF2  
 
PF11_0225 pfGCN20 
PF08_0078 
  
(NBD)2  
 (NBD)2 
 
815 
1419 
ABCG 
    ABCG1  
 
PF14_0244  
 
NBD-MSD  
 
660  
ABCI 
    ABCI1 
    ABCI2 
    ABCI3  
 
PF14_0133 
PF14_0321 
PFC0875w  
 
NBD 
NBD 
MSD-NBD-MSD  
 
347 
171 
3133 
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study show the signal to be intense on the outside, forming a clear rim in what can be 
interpreted as the parasite’s plasma membrane especially in the ring and trophozoite 
stages (Fig. 4.4, A - D). More clearly cytoplasmic staining was evident in the schizont 
stages (Fig. 4.4, B, C, and E), interpreted as plasma membrane partitions of the dividing 
parasites. Unfortunately, due to their small size detailed high magnification imaging of 
the non-dividing stages such as rings and young trophozoites was limited by the light 
resolution power of the microscope. PfMRP1 did not co-localize with PfERC, thus 
suggesting the absence of PfMRP1 on the endoplasmic reticulum membrane. For 
PfMRP2 specific staining was observed on the parasite’s plasma membrane (Fig. 4. 5, 
column 2). Low intensity signal was occasionally observed intracellularly especially in 
early schizont stages (Fig: 4. 5, D2) which can be considered to be plasma membrane 
partitions as the parasite undergoes cytokinesis. This is especially so as each of these 
partitions enclose a nucleus as clearly stained by DAPI (Fig. 4. 5, D4). PfMRP2 did not 
co-localize with PfERC in the endoplasmic reticulum (Fig. 4. 5, C and D) and no staining 
was observed in the region presumed to be the food vacuole (shown by arrow in Fig. 4. 
5, C5). PfMDR5 was clearly observed to localize to the surface of the parasite in all 
asexual stages (Fig. 4. 6). Trophozoite stages sometimes revealed a less intense 
intracellular staining around the food vacuole (Fig. 4. 6, B5 and D5). This pattern of 
staining though sometimes strong was not consistent in the many slides scanned. 
Instead the staining was sometimes seen around the nuclei of dividing trophozoites, 
which may also suggest these to be plasma membrane partitions as the trophozoite 
divides. Moreover, in the schizont stages the region covered by the food vacuole did not 
show any obvious staining with the PfMDR5 antibody, instead clear partitions were seen 
separating each of the individual nuclei (Fig. 4. 6, 2C).  
PfMRP1, PfMRP2 and PfMDR5 
 
 
 
Figure 4.6: Localization of PfMDR5 
In column 1 (blue, DAPI) shows the nuclear staining. In column 2 (red) shows PfMDR5 staining.  
In column 3 (green) shows glycophorin
4 shows the merge of column 1–
image. Represented in rows: A, rings; B, trophozoite; C, 
trophozoite; E, dividing trophozoite; F, schizont. Arrow indicates food vacuole.
 
In comparison with the endoplasmic reticulum marker PfERC, which localized as bright 
staining patches within the parasite, PfMDR5 Localized differently, forming a rim 
outside the PfERC staining in all stages (Fig. 4. 6, D
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-A (A, B, and C) or PfERC (D, E, and F) staining. Column 
3. Finally, column 5 shows the differential interference contrast 
schizont and ring (R); 
 
-F) (ring stages not shown). 
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Therefore, it is concluded that PfMDR5 is primarily expressed on the plasma 
membrane. 
 
Table 4.2: Transmembrane segments of PfMRP1, PfMRP2, and PfMDR5. The TM segments 
were predicted with TMHMM. TM segments in italic were weak probabilities. 
TM  PfMRP1  PfMRP2  PfMDR5  
1 121-143 133-155  88-111  
2 175-197  180-202  143-163  
3 318-340  402-424  181-203 
4 350-372  434-456  270-292 
5 426-448  517-539  365-387 
6 466-488  554-575  399-417 
7  1158-1180  1430-1452   
8  1218-1240  1473-1495   
9  1250-1272  1510-1532   
10  1293-1310  1553-1570   
11  1314-1333  1574-1593   
12  1392-1414  1654-1676   
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4.4 Discussion 
In the plasmoDB database 16 members of the P. falciparum ABC family can be 
identified, 11 of which could be putative drug efflux transporters. A phylogenetic 
analysis of the PfABC genes was performed and the genes were categorized into seven 
subfamily groups. Three ABC family members were analyzed in more detail and their 
expression in all erythrocytic stages as well as their localization at the plasma membrane 
of the parasite was demonstrated. Development of resistance against newly introduced 
anti-malarials can be rapid especially in malaria endemic regions where drug pressure is 
high. For instance mefloquine was introduced in Thailand in 1984 as a very potent drug 
against multidrug resistant malaria, but six years later significant resistance had 
developed (Nosten et al., 1991). Multiple studies have demonstrated the role ofPfMDR1 
polymorphisms in multidrug resistant malaria. It was shown that the anti-malarial 
drugs halofantrine, quinine and chloroquine are transported by PfMDR1 (Sanchez et al., 
2008). Moreover, polymorphisms within PfMDR1 alter the substrate specificity for 
these anti-malarial drugs (Sanchez et al., 2008). Recent association studies have linked 
single nucleotide polymorphisms on PfMRP1 with reduced parasite response to anti-
malarial drugs (Mu et al., 2003; Ursing et al., 2006) and expression of both PfMRP1 and 
PfMRP2 were up-regulated by mefloquine and chloroquine in laboratory cultures of 
both drug sensitive and resistant strains (Nogueira et al., 2008). This indicates that ABC 
transporters play a role in malaria chemotherapy (Price et al., 2004). The knowledge 
that other PfABC family members could be capable of drug transport indicates that it is 
likely that some of these transport proteins might play a role in emerging drug 
resistance. Further identification and characterization of these ABC transporters will 
provide information on their putative role in resistance and may provide novel targets to 
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control and perhaps prevent spread of resistance against other efficacious drugs. The 
PFAM search in plasmoDB resulted in 16 ABC family members that were also identified 
and categorized by others (Gangwar et al., 2009; Gardner et al., 2002; Sauvage et al., 
2009; Martin et al., 2005). ABC A subfamily members were not observed, but these 
seem to be absent in all Apicomplexa. The ABC B subfamily consists of seven members 
of which only PfMDR1 is a full transporter. The C subfamily contains two full 
transporters, whereas the G subfamily contains one half-transporter. Next to these ABC 
family members there is one additional member that contains a TMD. As this member 
does not belong to the existing subfamilies, it was placed in the I family that was 
proposed by Verrier et al (Verrier et al., 2008) to harbor “orphan” ABC components. 
Five ABC family members that do not contain TMDs are located in E, F, and I 
subfamilies. 
Recently, Gangwar and colleagues (Gangwar et al., 2009) analyzed the ABC 
family members of P. falciparum, their phylogenetic tree was, however, not based on an 
alignment of the conserved NDB regions but on the whole protein, which results in a 
phylogenetic tree where the subfamilies are not clustered. Moreover, they did not 
include ABCB4 (PFC0125w) in their analyses and included PFE0450w, which is not an 
ABC family member but a putative chromosome condensation protein. In a very recent 
review (Sauvage et al., 2009) the ABC families of different protozoan parasites were 
listed. They clustered the ABC family members in a way similar to our approach. In this 
study PF08_0078 was, however, assigned in the F family according to the phylogenetic 
analysis of both NBDs, whereas they categorized it as “other”. As they did not show a 
phylogenetic analysis it is not clear why this discrepancy exists. Moreover, PFC0875w 
(PfABCI3), that does not possess a clear ABC signature motif, but according to the 
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PFAM search belongs to the ABC family, is not listed in their overview. In this study the 
existing nomenclature for PfMDR1, PfMDR2, andPfMRP1, was not changed, but the 
nomenclature of Verrier et al (Verrier et al., 2008) for plant ABC proteins that was 
adopted from the HUGO nomenclature and discussed in several international meetings 
was used. This nomenclature essentially constitutes a catalogue with numbered entries, 
where the numbers do not necessarily carry additional information, although the 
subfamily assignment does indeed convey information about phylogenetic relationships 
(Verrier et al., 2008). The gene nomenclature recently published by Sauvage et al 
(Sauvage et al., 2009) is based on the nomenclature for Toxoplasma gondii (Sauvage et 
al., 2006), which as a consequence in P. falciparum resulted in the absence of ABCB2, 
ABCG1, ABCG2, ABCH1,and ABCH3 and the relocation of PfMDR2 to ABCB3. Such a 
nomenclature is, however, impractical for a group with relatively few orthologous 
pairings, such as the ABCs (Verrier et al., 2008). It is known that the malaria parasite 
can express its membrane proteins on at least four different subcellular sites: on its 
membrane-bound organelles, the plasma membrane, the parasitophorous vacuolar 
membrane and on the plasma membrane of its host erythrocyte (Kirk et al., 1999; 
Krugliak and Ginsburg, 2006). The expression of PfMRP1, PfMRP2, and PfMDR5 was 
observed on the outside of the parasite. It is practically impossible to distinguish the 
plasma membrane from the parasitophorous vacuolar membrane by 
immunocytochemistry. However, a detailed look at the expression of all three ABC 
transporters shows that they are also present on membranes between parasitic nuclei in 
the multi-nuclear stages of development. As these are plasma membranes in the process 
of formation, it is concluded that all three ABC transport proteins are located on the 
plasma membrane in all asexual erythrocytic stages of P. falciparum.  
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The localization of PfMRP1 at the plasma membrane has been shown by others 
(Klokouzas et al., 2004; Raj et al., 2009). An elegant control was shown in the recent 
study (Raj et al., 2009), where a P. falciparum knock-out of PfMRP1 was used. In this 
study, knock-out parasites were not available and as an additional control the antibody 
was affinity purified with the peptide that was used to immunize the rabbits. In 
addition, background staining with the erythrocytes was not observed indicating that 
the staining was specific. 
 
4.5 Conclusions 
16 ABC proteins were categorized according the phylogenetic tree that was 
constructed from the aligned NBDs. PfMRP1, PfMRP2, and PfMDR5 were localized at 
the plasma membrane of the parasite throughout the asexual stages. This localization 
emphasizes the putative role of drug exporters of these ABC family members. Indeed, 
others (Raj et al., 2009) have shown that PfMRP1 plays a role in the efflux of 
glutathione, chloroquine, and quinine and contributes to parasite responses to multiple 
anti-malarial drugs, possibly by pumping drugs outside the parasite. PfMRP2 and 
PfMDR5 might have similar roles and thereby broadening the capacity of the parasite to 
extrude toxic compounds. Additional research is required to test this hypothesis. 
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Summary  
Malaria is a major health problem that mainly affects the less economically 
developed countries of the world. The development of multidrug-resistant strains of the 
parasite and the lack of effective vaccines pose a great challenge to the control of 
malaria. Multidrug resistance mechanisms involve the ABC transporter family of 
membrane proteins. P. falciparum ABC transporters have been associated with 
antimalarial drug response. They complement the antioxidant defense systems of the 
parasite through glutathione transport thereby enhancing alternative heme 
detoxification pathways that are important in conferring antimalarial drug resistance. In 
this study we have cloned and sequenced four P. falciparum ABC transporters in 
addition to three others reported in a previous study. We tested expression of these 
genes in heterologous systems and investigated their protein expression levels in 
synchronized parasite cultures. Native PfMDR5-EYFP fusion fragments of up to 121 
amino acids were successfully expressed in HeLa and Sf9 cells. Expression levels 
decreased with increasing gene size. Codon harmonization improved the expression of a 
65 amino acids PfMDR5-EYFP fragment slightly, but not of the full-length transporter. 
Expression levels of PfMRP1, PfMRP2, and PfMDR5 in synchronized asexual stages of 
the parasite were not resolved due to background signals that are probably caused by 
erythrocytic spectrin proteins. We conclude that lack of efficient expression of P. 
falciparum proteins in the heterologous expression systems is due to factors that seem 
to be contributed by the AT richness, codon usage, and gene size. Novel strategies are 
required for the successful expression of large transmembrane P. falciparum proteins 
such as the ABC transporters. 
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5.1 Background 
Malaria is one of the most important widespread diseases in the world. About 
250 million people contruct malaria annually and results in about one million deaths 
every year (WHO, 2009). Among the four species of human malaria, Plasmodium 
falciparum is the most virulent and is responsible for most of the morbidity and 
mortality due to malaria. The other human malaria species are P. vivax, P. ovale, and P. 
malariae.  
The most important reason why malaria has remained a major health problem, 
despite being a disease known for centuries, is the emergence of multidrug resistance 
strains of the parasite that render the most cost-effective and safe drugs such as 
chloroquine ineffective. Currently, the number of effective antimalarial drugs is limited.  
The molecular mechanisms of drug resistance in the malaria parasite are complex and 
involve a number of membrane transporters that belong to the ATP Binding Cassette 
(ABC) protein superfamily. ABC transporters utilize the energy from ATP hydrolysis to 
actively export out of (sub)cellular compartments, a wide range of structurally and 
functionally diverse amphipathic compounds including drugs and metabolites (Dassa 
and Bouige, 2001; Dean et al., 2001a). A typical ABC transporter consists of six 
membrane spanning segments that form a transmembrane domain (TMD) and highly 
conserved Walker A and Walker B motifs that form a nucleotide binding domain (NBD) 
(Dean, 2005). ABC transporters are either encoded as full transporters with two TMDs 
and two NBDs or as half transporters with one TMD and a NBD. A functional ABC 
transporter consists of a 2(TMD-NBD) structure. ABC transporters are involved in 
various diseases either by a mutation or through an altered mode of their expression 
(Dean and Annilo, 2005; Klokouzas et al., 2003).  
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The involvement of ABC transporters in antimalarial drug resistance has been 
documented. For instance specific polymorphisms and increased copy number of the 
PfMDR1 gene are associated with drug resistance (Valderramos and Fidock, 2006). 
Furthermore, PfMDR1 mutations commonly associated with drug resistance were 
shown to exhibit altered drug specificity (Lekostaj et al., 2008; Sanchez et al., 2008). 
Recently, in vitro drug susceptibility studies showed that two ABC transporters 
belonging to the ABCC subfamily, PfMRP1 and PfMRP2, influence the parasite’s 
response to antimalarials (Nogueira et al., 2008; Ursing et al., 2006). More importantly, 
PfMRP1 polymorphisms have been identified in the field and found to affect 
susceptibility to quinoline antimalarials (Ursing et al., 2006; Dahlstrom et al., 2009). 
Moreover, PfMRP1 was recently shown to transport antimalarial drugs and glutathione 
(Raj et al., 2009a). Next to this, ABC transporters through their ability to transport 
glutathione are thought to contribute to the antioxidant defense systems of the parasite 
by enhancing heme detoxification pathways alternative to polymerization into 
hemozoin. The alternative heme detoxification via glutathione is important in 
conferring resistance to antimalarial drugs. Drug resistant parasites increased 
glutathione metabolism and reduced hemozoin accumulation (Davioud-Charvet et al., 
2001; Dubois et al., 1995; Platel et al., 1999). 
A total of 16 ABC genes are present in the P. falciparum parasite. In a previous 
report (Kavishe et al., 2009) we classified these transporters into different subgroups 
and showed that 11 of these genes encode membrane transporters. We also reported 
cloning and sequencing of PfMRP1, PfMRP2, and PfMDR5. In this study we cloned and 
sequenced four additional P. falciparum ABC transporters. We investigated the 
expression of PfABCs in heterologous systems and we successfully expressed small 
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pieces of PfMDR5 in Sf9 insect and HeLa cells. Full-length PfABC genes, however, could 
not be expressed in these systems due to factors as gene size, codon usage and A/T 
richness. We also attempted to investigate the differences in expression levels of 
PfMRP1, PfMRP2, PfMDR5, and PfMDR3 in the synchronized asexual stages of the 
parasite, but due to high background caused by unspecific binding of antibody to 
erythrocyte spectrin proteins, we could not detect these transporters on Western blot. 
 
5.2 Methods 
Parasite cultures: NF54 (Amsterdam airport) strain of P. falciparum was 
cultured as described by Ponnudurai et al., (Ponnudurai et al., 1986). The culture 
medium (Ifediba and Vanderberg, 1980) was changed twice daily. Synchronization was 
performed using gelatin (Pasvol et al., 1978) and sorbitol (Jensen, 1978; Lambros and 
Vanderberg, 1979). 
Parasites extraction, genomic DNA and RNA extraction: Infected blood 
culture was centrifuged at 1000 g for 5 minutes to collect RBCs. After washing 2 times 
with PBS the cells were resuspended in 0.05% saponin in PBS and incubated at 37 oC for 
30 minutes. Then the sample was centrifuged at 2000 g for 10 minutes to collect the 
parasites. Parasite cells were washed twice with PBS and genomic DNA was isolated 
using the QIAamp DNA mini kit (Qiagen, Venlo, The Netherlands) following the 
cultured cells protocol as directed by the manufacturer. RNA was isolated using 
standard Trizol (Guanidinium isothiocyanate) method. Briefly, 500 µl Trizol reagent 
(Invitrogen) was added to the parasite pellet followed with 2.5 µl glycogen solution (18 
mg/ml), the mixture was homogenized with a pipette and incubated on ice for 5 min, 50 
µl chloroform was added and after shaking thoroughly the mixture was incubated on ice 
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for 10 min. Centrifugation at 13000g for 15 min at 4 oC separated the mixture into upper 
aqueous and lower chloroform phases. The aqueous phase which contains RNA was 
transferred into a fresh tube and 240 µl isopropyl alcohol was added, mixed by vortex 
and incubated on ice for 10 min prior to centrifugation at 13000 g for 20 min at 4 oC. 
The supernatant was discarded and the RNA pellet was air-dried and dissolved in 20 µl 
DEPC treated water. RNA was stored at -20 oC until use.  
PCR cloning and sequencing of PfABC genes: Unless otherwise specified, 
all primers were purchased from Biolegio, Nijmegen the Netherlands. cDNA was 
synthesized with superscript-II reverse transcriptase and oligo-dT primers (Invitrogen) 
and approximately 100 ng total RNA following the manufacturer’s protocol. Gene-
specific cDNA amplification was performed using the Takara LA Taq (TAKARA bio. Inc, 
Japan) following the outlined protocol by the manufacturer with some modifications. In 
short, annealing was done at 58 oC for 30 sec, extension at 62 oC for 2 min/kb, 25 cycles 
with final extension at 72 oC for 5 minutes. The forward and reverse primers of each of 
the pairs listed on Table 1 contained attB1 and attB2 gateway sequences respectively on 
the 5' end. The PCR products were purified with PEG buffer supplied with the BP-
clonase kit (Invitrogen) as recommended by the manufacturer.  
Cloning: PEG-purified products were cloned into pDONR-221 entry-vector 
(Invitrogen) using BP clonase kit (Invitrogen). The resulting recombinant DNA 
constructs (gateway entry constructs) were amplified in competent DH5α E. coli cells 
(Invitrogen) and selected against kanamycin. Positive constructs were extracted from 
the kanamycin resistant cultures using GenElute plasmid miniprep kit (Sigma, 
Germany) or JETstar plasmid purification midiprep kits (Genomed, GmbH). 
Sequencing was done using ABI3730 analyzer (Applied biosystems Inc.) facility of the 
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Radboud University Medical centre. Sequences were analyzed by multiple alignments 
using the web-based EBI Clustalw version 2 at: 
 http://www.ebi.ac.uk/Tools/clustalw2/index.html. A VSV-tagged PfMDR7 was 
generated by performing a PCR with a primer containing VSV tag on the PfMDR7 
gateway entry construct. Expression constructs were generated from the entry 
constructs by the standard LR-clonase reaction (Invitrogen) as described by the 
manufacturer. The pFastBacDual-VSV-CMV destination vector for mammalian cell 
expression (El-Sheikh et al., 2007), PT7Ts and the PDest8 (Invitrogen) for expression in 
oocyte and insect cells were used, respectively. The harmonized PfMDR5 gene was 
ordered from MrGene GmbH, Germany and after PCR with attB primers cloned with BP 
and LR reaction in the entry and expression vectors.  
Generation of PfABC baculovirus: For expression of ABC proteins in Sf9 
insect cells and HEK293 cells baculovirus was produced by using the Bac-to-bac 
baculovirus expression system (Invitrogen) as described in the manufacturer’s manual. 
Expression in Sf9 insect cell system: 50 ml Sf9 cells of 1.5 × 106 cells/ml 
Xpress medium (Biowittaker, Walkersville, MD) in the presence of 0.1% (w/v) pluronic 
F 68 (ICN, Aurora, OH) were infected in a 250 ml Erlenmeyer flask with 2 ml virus for 3 
days at 27 oC. Sf9 cells were harvested by centrifugation at 3000 g for 5 min. The pellet 
was resuspended in water containing protease inhibitor cocktail (Roche Diagnostics, 
Germany) and 0.1 mg/ml DNAse (Invitrogen, USA) and subsequently lysed by freeze-
thaw cycle in liquid nitrogen. Membranes were then extracted by centrifugation at 
20000 g for 10 min. 
Expression in HEK293 cells: HEK293 cells were cultured in 182 cm2 flask 
until 70% confluence in DMEM supplemented with 10% fetal calf serum at 37 oC under 
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5% CO2 humidified air. The culture medium was removed and 1.5 ml of virus and 3.5 ml 
medium was added and cells were incubated at 37oC for 15 minutes then 20 ml medium 
was added. One day post transduction sodium butyrate (5 mM) was added. After three 
days the cells were harvested by centrifugation at 3000 g for 10 minutes. Membranes 
were extracted as described above. 
Transfection of HeLa cells: HeLa cells were used for the expression of EYFP-
tagged PfMDR5 fragment pieces. Cell culture was started at about 5 x 105 cells/ml/well 
on a 12 wells culture plate (Greiner Bio-One, USA) and incubated at 37ºC for 2 hrs. 
Meanwhile 1.6 µg of plasmid DNA was diluted in 100 µL Opti-MEM and mixed gently. 
In another tube 4 µl Lipofectamine (Invitrogen) was diluted in 100 µL Opti-MEM and 
mixed carefully. Five minutes later, the two solutions were combined and incubated at 
room temperature for 30 min. The mixture was added to the seeded HeLa cells and 
incubated at 37ºC. After 24 hours the medium was refreshed and 5 mM of butyrate was 
added. Three days post transfection, cells were viewed under a fluorescent microscope 
to assess expression levels and subsequently the cells were harvested by loosening them 
with trypsin-EDTA (0.05% Trypsin and 0.02% EDTA) and subsequent centrifugation at 
3000 g for 5 minutes. Membranes were extracted as described above. 
Expression in Xenopus laevis oocytes: Heterologous expression in oocytes 
was carried out as described previously (Qiu et al., 2003). Briefly the appropriate 
PT7Ts-PfABC constructs were linearized and cRNA was synthesised using the T7 
mMessage mMachine kit (Ambion, Austin, TX). Individual prophase-arrested oocytes 
stage V to VI were obtained by partial ovarectomy from anesthetized Xenopus laevis 
females, followed by collagenase treatment. Each cell was injected with 10–15 ng PfABC 
cRNA and were incubated in modified Ringer's solution (90 mM NaCl, 2 mM KCl, 2 mM 
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CaCl2, 5 mM MOPS, pH 7.4) containing 1 mg/ml penicillin/streptomycin at 18 °C.  3–4 
days post-injection 10 – 20 oocytes were harvested and total membranes were extracted 
and analyzed on western blot. 
Antibody production: Antibodies against PfMRP1, PfMRP2 and PfMDR5 
have been described previously (Kavishe et al, submitted). For PfMDR3, PfMDR6, 
PfMDR7 and PfABCG1 short peptides corresponding to the sequences in Table 2 were 
synthesised and used to generate antibodies in rabbits (EZ Biolab, USA).  
Western blotting: For western blotting cultured cell or parasite pellets were 
lysed and homogenized in water containing a DNAse (Invitrogen, USA) and protease 
inhibitor cocktail (Roche diagnostics, Germany). When desired, membranes were 
extracted. Protein determination was performed following the modified Lowry method 
according to Peterson (Peterson, 1983) using bovine serum albumin as a standard. Non 
infected erythrocyte membrane ghosts (used as controls) were extracted by lysing 
erythrocytes in water containing protease inhibitors as described above and centrifuged 
at 25000 g for 10 minutes. The pellet was dissolved in Laemli buffer and incubated at 65 
°C for 10 minutes, and loaded on 7.5 % SDS polyacrylamide gel and subsequently 
blotted on nitrocellulose paper using the iBlot kit and apparatus (Invitrogen, USA). 
After staining the blots with the appropriate anti-PfABCs and anti-rabbit Alexa fluor 
680 – 800 secondary antibodies (Molecular probes, Netherlands) were visualized by 
Odyssey infrared imaging system (Li-Cor Biosciences). 
  
  
 
 
5.3 Results 
Cloning and sequencing of the PfABC genes
high fidelity and proof reading capacity such as Pfu we could not produce PCR products 
for the full-length cDNA. We therefore used Takara LA taq for amplification 
genes. PCR-products of 5469 and 6327 base pairs were obtained for PfMRP1 and 
PfMRP2, respectively. PfMDR5, PfABCG1, PfMDR6, PfMDR7, and PfMDR3 gave PCR
products of 2778, 1983, 3150, 2668, and 2619 base pairs, respectively (Fig. 
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. Despite using enzymes with 
 
Figure 5.1:  PCR products of 
Plasmodium falciparum ABC genes 
indicating their size in base pairs (bp). A: 
pfmrp1 and pfmrp2; B, PfMDR5, PfABCB7, 
PfABCB6, PfABCB3 and PfABCG1. 
products were cloned into baculovirus 
gateway expression vectors for human 
embryonic kidney cells (HEK293) and 
insect cells (Sf9). PfMRP1, PfMRP2, 
PfMDR5 and PfABCB7 were also cloned 
into a vector for the Xenopus laevis oocyte 
expression system.  
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Figure 5.2: Schematic representation of the strategy used to produce PfMDR5-EYFP fusion 
fragments. See section Materials and Methods for description. 
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To generate constructs for expression in various systems we first generated the 
Gateway ENTRY constructs by cloning the PCR products into pDONR221. The 
respective Entry constructs of each ABC transporter were sequenced. The sequencing 
results were in conformity to the genomic sequences in the Plasmodium database at the 
www.plasmodb.org with exception of PfMDR3, the sequence of which contained a 
stretch of 20 T nucleotides and a 45 Adenylate repeats. Due to low proofreading activity 
of the TAKARA polymerase enzyme kit used, all of the constructs generated contained 
mutations (base substitutions, insertions or deletions). Multiple PCR reactions showed 
that the location and type of the mutations differed between PCR products and thus 
were not polymorphisms but introduced by the amplification. With repeated PCR and 
cloning, we obtained constructs free from missense mutations except for PfMRP2 which 
contained 2 missense mutations. All the remaining constructs contained few (1 to 3) 
synonymous mutations. Because of the insertion in PfMDR3, we decided not to continue 
with this construct for expression experiments.  
Antibodies for the P. falciparum ABC proteins. Polyclonal antibodies 
against PfMDR5, PfMRP1, and PfMRP2 have been described in our previous study 
(Kavishe et al, 2009). Table 5.1 illustrates peptide sequences for the other four ABCs. All 
antibodies were initially tested in immunocytochemistry experiments with P. 
falciparum infected erythrocytes. Preliminary experiments showed the PfMDR5, 
PfMRP1 and PfMRP2 antibodies to be very specific in immunocytochemistry and 
therefore the expression experiments were focused more on these three transporters. 
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Table 5.1: Peptides used in the generation of antibodies against different P. falciparum ABC 
transporters and the primer pairs used to amplify and clone ABC genes. The primer sequences 
in this table do not include the attB sequence for gateway cloning.  
 
ABC  
 
Peptide sequence  
 
Location within the predicted protein 
sequence  
PfABCB3 YETLISHKTELLTS  734 – 747  
PfABCB6 IKYVPYKNKIITLAC  223 – 237   
PfABCB7 KISVLKQEKLSSCID  367 – 381  
PfABCG1  TTIISSLHQPSSQV  210 – 223  
   
 
ABC  
 
Primer name  
 
Primer sequence  
Pfmrp1 Pfmrp1F ATGACGACATATAAAGAAAATGTTG  
Pfmrp1R TTAGTCGTCCATTTCTAACAAATGTG  
   
Pfmrp2 Pfmrp2F ATGATGAGACGGAGAAGCGTTTAC  
Pfmrp2R TCAATTTAATTGTTTTTCTTGAAGCAAG  
   
PfABCB3 PfABC-11-0466attB1F ATGCGTAATTATGGGTTATTGCATTTTTTG 
PfABC-11-0466attB2R TTATTTGTTATCCRGAATTTTTTTTGTCTCG 
   
PfMDR5 PfABC-13-0218attB1F ATGGGTAATAGCTTATCGTTATGCCTAC 
PfABC-13-0218attB2R CTATAGAGCAGGCTTATGTAGGGAG 
  
PfABCB6 PfABC-13-0271attB1F ATGCGCAGTTTTTATAATAAATGTTTTACG 
PfABC-13-0271attB2R TTATAACATTTTATTATTCTTTGAGTCG 
   
PfABCB7 PfABC-L0495c-attB1F  ATGATAATAAAACGGCATCTGATAAACTAC 
PfABC-L0495c-attB2R  ATTCACTCACACCTTGTGTAAG 
   
PfABCG1 PfABC-14-0244attB1F  ATGGATTTGAAAGGGTGGATTTCC 
PfABC-14-0244attB2R  TCATTTCATTTTTAAGGCTTGGGACCATC  
 
In vitro expression of the P. falciparum ABC transporters. Table 5.2 
summarizes the results of the expression of ABC transporters in different heterologous 
systems. Initially PfMRP1 and 2 were the first to be cloned and tested in HEK293 cells, 
but we did not observe expression. Then we decided to clone the other half transporter 
ABC genes (PfMDR3, PfMDR5, PfMDR7, PfMDR6, and PfABCG1). Because cloning of 
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PfMDR7 went quicker than the others, and the antibodies were still in production, we 
also included a VSV-tag in PfMDR7 for easy screening with standard anti-VSV 
antibodies and tested its expression in HEK293 cells. However, we did not observe any 
expression. When the antibodies were available, PfMDR5 was tested in HEK293 and Sf9 
cells and we did not detect expression. Optimization for virus quality and repetition of 
the experiment was performed but the results did not improve. Subsequently, no 
expression was found in Sf9 cells using the baculovirus system. Next we tested 
expression in Xenopus laevis oocyte. cRNA was synthesized from PfMRP1, PfMRP2 and 
PfMDR7-vsv. Between 20 and 50 oocytes per construct were injected with cRNA. 
Control oocytes were injected with DEPC-treated water. The expression level between 
cRNA-injected oocytes and water injected oocytes did not differ as determined by 
western blotting. This experiment was repeated once and gave similar results.  
Then we focused on the codon usage and gene size for heterologous expression. 
We designed a strategy where pieces of increasing size of PfMDR5 were tagged to the 
Enhanced Yellow Fluorescent Protein (EYFP) (Fig. 5.2) and checked for expression 
levels in HeLa and Sf9 cells. Since EYFP is efficiently expressed in the insect and 
mammalian cell systems, it served as a control to monitor the levels of expression of the 
ABC peptides. Moreover EYFP fluorescence was utilized to detect very low expression 
levels under fluorescent microscope. Four constructs were generated, C0, C1, C2, and C3 
with 18, 65, 121, and 273 amino acids, respectively, coupled to EYFP. HeLa cells 
transduced with C0, C1, C2, and C3 displayed a decreasing number of fluorescent cells 
expressing EYFP (Fig. 5.3). Interestingly, construct C0, with only 18 codons, displayed 
very high levels of fluorescence comparable to the EYFP expressing positive control. 
When these cells were harvested and checked by western blotting, only C0 and C1 were 
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detectable. Remarkably, expression of C0 was very low (about 10 times lower) compared 
to the positive control while C1 expression was far much lower (Fig. 5.4).   
Next the experiment was repeated in baculovirus infected Sf9 cells. C1 and C2 
were fairly expressed in Sf9 cells compared to the positive control with C1 displaying 
slightly higher expression levels than C2, while there was no correct product for C3 (Fig. 
5.5A). Instead, two products of lower molecular weight were observed for C3, one 
corresponding to the EYFP protein size and the other slightly higher. These products 
could represent degradation of C3. Additionally, C1 and C2 also contained appreciable 
amounts of lower molecular weight products. The expression in Sf9 was generally higher 
than that observed in HeLa cells. 
To check for the effect of codon usage on expression levels, we harmonized C1 
and the full-length PfMDR5 cDNA sequence. When these constructs were tested for 
expression, the harmonized C1 had slightly higher expression than the non-harmonized 
C1 in Sf9 cells (Fig. 5.5B). Expression of both harmonized and non-harmonized full-
length PfMDR5 was not detected on western blot (data not shown). 
  
 
 
 
 
Figure 5.3: Expression of PfMDR5
cells. EYFP, positive control; C0, with 18 a. a.; C1, 65 a. a.; C2, 121 a. a.; C3, 272 a. a. and 
negative control, non-transected cells. HeLa cells were seeded at 
well cell culture plate and transected with the respective constructs. After 24 hrs, expression 
was boosted with 5 mM sodium butyrate. After 72 hrs the cells were viewed under 
fluorescent microscope. Expression level decreased w
fragment. 
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Figure 5.4: Expression of PfMDR5
and homogenized in Laemli buffer before loading on SDS
fragments with 18, 65, 121 and 273 amino acids, respectively. NT, non transected negative 
control. Arrow, the expected C1 peptide 
 
Figure 5.5: Expression of P. falciparum MDR
represent the fragments with 65, 121 and 273 amino acids, respectively. NT, non
cells (negative control) and EYFP, positive control represent cells expressing only EYFP. 
comparison of expression levels between native forms of C1, C2 and C
between codon-harmonized and native C1 fragments. Sf9 cells were seeded at 5*10
a 25 cm2 cell culture flask and transected with the respective baculovirus containing the 
construct of interest and incubated at 27
were analyzed on western blot.  
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Figure 5.6: Analysis of expression levels of PfMRP1 and PfMRP2, PfMDR5 and PfCRT in 
synchronized asexual stages  of Plasmodium falciparum (NF54).  PfMRP1 predicted size is 214 
kDa, PfMRP2, 249 kDa, PfMDR5, 108 kDa and PfCRT, 44 kDa. Parasites were extracted by 
saponin permeation and homogenized in Laemli buffer before analysis on SDS
of approximately the correct size of all the transporters are present in varying level
parasite extracts.   
 
Analysis of in vivo expression levels of the ABC transporters
the level of in vivo expression of the transporters we used synchronized 
cultures. Synchronized stages of parasites were homogenized in Laemli buffer and 
analyzed on western blot (Fig. 
of about 200 kDa was consistently observed with the anti
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amount of this protein varied with the parasite’s lifecycle stages in rings and schizonts 
samples, showing slightly higher expression than the trophozoite stage. The predicted 
size of PfMRP1 protein is 214 kDa. For PfMRP2, predicted as a 249 kDa protein, a 
protein of higher than 250 kDa was observed in all parasite stages with highest level in 
the ring stage, while expression in the trophozoite stage was slightly lower than in the 
schizonts. Similarly, a consistent signal was observed for the half transporter PfMD
the expected molecular weight of 109 kDa and its expression levels were almost equal in 
all the three stages. Additionally, a 200 kDa product was observed and assumed to be a 
dimmer of the 109 kDa product. The same parasite sample was checked for the
falciparum chloroquine resistant transporter (PfCRT), which is  normally observed at 
44 kDa (Fidock et al., 2000) and here at around 40 kDa. Moreover, the PfCRT antibody 
also recognized protein products of about 37 kDa and 100 kDa (Fig. 
Figure 5.7: Specificity analysis of anti
total lysine and membrane extracts on western blot. All antibodies recognize characteristic 
two peptides thought to be alpha
nonspecific background signal but coincides with the expected sizes of the respective PfABC 
proteins except for PfCRT. Arrows indicate bands coinciding with the predicted parasite 
protein.  
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To check for the specificity of the antibodies on western blotting, non-infected 
erythrocyte total lysates and ghost membrane extracts were compared on western blot 
(Fig. 5.7). Surprisingly, all the antibodies including anti-PfCRT recognized characteristic 
two peptides at above 250 kDa. Additionally, PfMDR5 and to a lesser extent PfCRT, 
PfMRP1 and 2 antibodies recognized a peptide at around 100 kDa, similar to the one 
observed with anti-PfMDR5 in parasite extracts. The signals were more abundant in the 
erythrocyte membrane extracts than in the total lysates, suggesting these to be 
membrane proteins. However, the peptide sequences used to generate the antibodies 
were used to blast-search the protein database and could not retrieve any related 
sequences and the antibodies were specific in immunocytochemistry. We therefore 
speculated that erythrocyte ghost membrane contamination had occurred during 
parasite extraction. Parasite extracts were checked on western blot with anti-
glycophorin-A antibody and there was a low amount of glycophorin-A signal compared 
to erythrocyte ghost controls (data not shown). These results were suggestive of 
contamination from membrane associated proteins that could break free from the 
erythrocyte membrane and stick to the parasites during the extraction process. Due to 
limited time we could not continue this investigation.  
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Table 5.2: Summary of results from expression of P. falciparum ABC gene constructs in 
different heterologous systems.  
ABC gene  Expression in:  
 HeLa Sf9 insect HEK293  X. laevis oocytes**  
PfMRP1 No  No  No  No  
PfMRP2 No  No  No  No  
PfAMDR5 No  No  No   
PfABCB5-harmonized No  No    
     
PfABCB6     
PfABCB7  No  No  No  
PfABCB7-vsv tag  No  No  No  
PfABCG1     
PfMDR5 fragments     
 C1 Expressed  Expressed    
 C1-harmonized Expressed  Expressed    
 C2 Low  Expressed    
 C3 Very low  Expressed    
**experiment performed only twice.  
 
5.4 Discussion 
The lack of effective vaccines and the ever growing resistance to antimalarial 
drugs urges the search for new drugs or improved drug therapies. In order to speed this 
up, understanding the mechanisms utilized by the parasite to achieve multidrug 
resistance is required. However, this has been hampered by the lack of a standard 
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expression system for falciparum genes. Only few genes have been functionally 
expressed and characterized despite the availability of the genomic sequences for more 
than a decade now. In this study we have cloned seven falciparum ABC genes, four of 
which we attempted to express in heterologous systems. The first challenge in cloning P. 
falciparum genes is their amplification by PCR. Due to the high A/T richness (about 
80%) of the falciparum genes, high fidelity DNA polymerases did not yield PCR 
products with long cDNA amplifications. Our amplification products ranged from 1983 
to 6327 base pairs. We used TAKARA taq polymerase with proofreading activity but still 
obtained many base substitutions, deletions and insertions. Most insertions and 
deletions occurred at A/T stretches characteristic of falciparum genes. The difficulties in 
cloning falciparum genes has been reported by others, especially the occurrence of 
deletions and insertions at the A/T stretches of the genes even when high fidelity 
enzymes are used (Mehlin et al., 2006). The use of the gateway cloning system is a 
convenient and fast method to switch from one expression vector to another. This has 
enabled us to clone the falciparum ABC genes relatively fast, but the screening for 
constructs free from PCR-introduced mutations was time consuming. We generated the 
expression vectors for the Sf9 baculovirus expression system, mammalian HEK293 and 
Xenopus laevis oocyte expression systems. We decided to focus on PfMRP1 and PfMRP2 
because of their putative role in glutathione transport and on PfMDR5 because of its 
relatively small size. We first cloned and tested expression of native PfMRP1 and 
PfMRP2 (5469 and 6327 bp, respectively) in Sf9 and HEK293, but we observed no 
expression on western blot, and optimization experiments did not improve expression. 
One of the reasons could be the large size of these genes. We have shown that fragments 
of PfMDR5 attached to EYFP were expressed in low amounts in human HeLa cell line 
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and fairly higher amounts in baculovirus infected Sf9 insect cells. These results show 
two important aspects: a difference between the expression in the two systems (HeLa 
and Sf9) and an effect of gene size in expression. We can conclude that it is likely for 
expression of P. falciparum genes to succeed in Sf9 cells than in mammalian cells. What 
we do not know is whether this expression will vary with gene composition. For 
instance, others have shown that while some falciparum genes were not expressed in E. 
coli, others of similar size were rather easily expressed (Mehlin et al., 2006). But 
perhaps the most interesting part of our findings is the effect of gene size on expression 
levels in both HeLa and Sf9 cells. In the HeLa cells expression of 18 (C0), 65 (C1), 121 
(C2), and 273 (C3) amino acids attached to EYFP decreased with increasing size of ABC 
sequence. Most remarkably is the approximately 10-fold reduction in EYFP expression 
by attaching only 18 PfMDR5 amino acids (C0) (Fig. 5.4). The 54 base pair sequence (18 
amino acids) does not contain the long A/T stretches characteristic of falciparum genes 
and its A/T content was 62%. Both C1 and C2, in addition to their expected products, 
gave a 29 kDa product, which equals the size of EYFP plus approximately 50 base pairs 
preceding a 35 A/T repeat with a single G base. Therefore it is possible that truncation 
occurred after 54 base pairs of the PfMDR5 sequences due to the A/T stretch, which 
could provoke mRNA termination. However, a similar expression pattern was observed 
with the codon harmonized C1 fragment (Fig. 5.5B). Codon harmonization reduced the 
A/T richness of the 35 base pair region mentioned above from 97% to 66%, but short 
stretches of 4 to 6 A/T remained. Termination of protein expression by A/T rich 
stretches is supported by others. For instance, truncation of falciparum proteins has 
been reported in E. coli and in yeast where the long stretches of adenylates are thought 
to give false mRNA termination signals leading to immature termination and eventually 
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truncated proteins (Mehlin et al., 2006; LaCount et al., 2009). In S. serevisiae, full-
length P. falciparum proteins were more successfully expressed in cells carrying 
mutations on the proteins involved in mRNA-3' processing than in those with wild-type 
enzymes (LaCount et al., 2009). Expression of C3 construct with 91 amino acids was not 
successful in Sf9 cells, but it gave two small products of about 27 and 28 kDa that are 
presumably breakdown products.  
 Other factors are responsible for poor or lack of expression of falciparum genes. 
Apart from A/T richness, which seems to be a major factor, molecular weight, isoelectric 
point and codon usage were found to affect both expression and solubility of falciparum 
proteins (Mehlin et al., 2006). Gene size, isoelectric point and low complexity regions 
within proteins have been reported to affect heterologous protein expression in general 
(Birkholtz et al., 2008). We have harmonized the C1 fragment and the full-length 
PfMDR5. We showed that expression of the harmonized C1 was slightly better than the 
native form; however, full-length PfMDR5 expression was not improved by 
harmonization. Codon optimization, use of rare tRNA supplemented systems or the 
combination the two has been shown to improve P. falciparum gene expression 
(Burgess-Brown et al., 2008; Narum et al., 2001; Yadava and Ockenhouse, 2003; Baca 
and Hol, 2000). Interestingly, PfMDR1 and PfCRT were expressed in yeast after codon 
optimization and removal of some signal sequences, while in Xenopus laevis oocytes no 
optimization was required for PfMDR1, PfATPase6, and PfATPase4 (Eckstein-Ludwig et 
al., 2003; Krishna et al., 2001; Sanchez et al., 2008). In mammalian cells, optimization 
was required for PfCRT expression in HEK293 cells (Reeves et al., 2006), while PfMDR1 
in CHO cells did not require codon change (Van Es et al., 1994). Therefore it is not 
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predictable which strategy may be required for a successful expression of a target 
protein in a given system and multiple strategies may be required.  
 Finally, we investigated the in vivo expression levels of PfMRP1, PfMRP2, and 
PfMDR5 in synchronized stages of the parasite. We observed in the different parasite 
stages proteins related to the predicted PfABC transporters in terms of size (molecular 
weight). These proteins were, however, also observed in non-infected red blood cells 
(Fig. 5.7) and are assumed to be erythrocyte spectrin proteins. About 240 copies of 
spectrins are present in the erythrocyte of which α-spectrin (280 kDa) migrates as 240 
kDa and β-spectrin (246 kDa) migrates as 220 kDa on SDS-PAGE (Gallagher and 
Forget, 1993).  The sizes of spectrins coincide with the sizes of the expected parasite ABC 
proteins studied in this report thus complicating the interpretation of the results. The 
PfABC antibodies used in this study have been tested on immunocytochemistry and 
displayed a high specificity (Klokouzas et al., 2004; Kavishe et al, 2009). It is therefore 
possible that the observed signal on western blot is a combination of both the correct 
PfABC signal and spectrin background. PfCRT was used as a positive control and we 
specifically identified PfCRT expression in the parasite extracts at around 40 kDa. 
Further optimization and perhaps using anti-spectrin antibodies control for the 
background is required to establish the correct PfABC signal and determine the 
expression profiles of the plasmodial ABC proteins. 
 
5.5 Conclusions 
 Development of drug resistance to antimalarial drugs by the malarial parasites is 
thought to be achieved by mechanisms that involve the multidrug resistance proteins 
(MDR and MRP), which belong to the ATP-binding cassette protein family. In order to 
  Chapter 5 
  
 
- 127 - 
understand these mechanisms and to speed up the search for new therapeutic agents, 
heterologous expression and characterization of these plasmodial proteins is necessary. 
We have cloned and sequenced four PfABC proteins in addition to the 3 previously 
reported. We have tested expression of PfMRP1, PfMRP2, PfABCB7, and PfMDR5 in 
different eukaryotic heterologous systems. We have successfully expressed PfMDR5-
EYFP fusion fragments of up to 65 and 121 amino acids in HeLa and Sf9 cells, 
respectively. Expression in baculovirus infected Sf9 cells was better than in HeLa cells. 
Harmonization of gene sequences did not improve expression of full-length PfMDR5. 
Heterologous expression of the P. falciparum genes may be affected by a combination of 
A/T richness, codon usage and gene size. Multiple strategies may, however, be required 
for successful expression of full-length ABC proteins. Expression levels of the PfABC 
transporters in synchronized parasites remain to be investigated.  
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6.1 General discussion  
Malaria has remained a major health problem despite many efforts to control it. 
Drug resistance and lack of effective vaccines contribute to the continued high morbidity 
and mortality due to malaria. While malaria infection is characterized with heme-
induced oxidative stress, the host immune response to the infection increases the 
oxidative stress burden. Although oxidative stress has a positive effect regarding 
clearance of the infection, it depends on the site where the stress is exerted (Postma et 
al., 1996). Evidence shows that oxidative stress in the erythrocytes speeds up parasite 
clearance as demonstrated by conditions such as G6PD deficiency and alpha thalasemia 
or by drugs known to induce oxidative stress. On the other hand, oxidatively stressed 
erythrocytes exacerbate malaria pathology. Oxidized red blood cells lose their 
deformability, which may eventually lead to clogging of microvasculature and 
subsequently tissue hypoxia. In addition, accelerated hemolysis and anemia may also 
cause tissue hypoxia (Dondorp et al., 2002). As a result, lactic acidosis, respiratory 
distress and damage of tissues are commonly observed in severe malaria (Becker et al., 
2004). Glutathione (GSH) is a central antioxidant in malaria that is utilized by the 
parasite in the detoxification of heme, a mechanism that confers drug resistance. GSH is 
oxidized to GSSG and needs to be recycled through reduction by GSH reductase. It has 
been observed that the parasite effluxes GSSG into the host cell possibly for reduction 
and recycling (Atamna and Ginsburg, 1997). Glutathione S transferases (GSTs) can 
conjugate drugs and metabolites with GSH forming conjugates that are excreted out of 
the cell. GSTs also possess peroxidase activity and utilize GSH in reduction of reactive 
oxygen species (Hurst et al., 1998). ABC transporters are responsible for the active efflux 
of both GSSG and GSH conjugated drugs or metabolites.  
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In this thesis we investigated the role of human GST mu, pi, and theta 
polymorphisms in susceptibility to severe malaria. In chapter 2 and 3 we have shown 
association of GSTM1-null and GSTP1 I105V variant genotypes with severe malaria. 
These results indicate the involvement of GSTs in the protection against severe 
falciparum malaria. GSTM1-null individuals have a deletion of the gene and also GSTP1 
I105V variants have almost no enzyme activity. GSTs function in the detoxification of 
several metabolites and harmful compounds. Studies show that GSTs can bind to heme 
(Harvey and Beutler, 1982) and GSTs may thus be involved in the detoxification of heme 
that escapes polymerization in the parasite. Our study was the first to investigate the 
role of GST polymorphisms in severe malaria. While their precise role remains to be 
investigated further, GSTM1 and GSTP1 are expressed in erythrocytes as well as in many 
other tissues including immune cells. It is thus possible that the protective effect of GST 
is exerted at various tissues that are involved in the clinical presentation of malaria. The 
effect of oxidative stress on the host cell in malaria is well known in conditions such as 
G6PD deficiency where drugs like primaquine are known to induce serious hemolysis 
and thus exacerbating pathology. Less oxidatively active treatment options are 
prescribed for such patients. Currently with the emergence of resistance to most 
conventional drugs, strategies to generate new antimalarial compounds are at various 
levels of evaluation. Such compounds are targeted to different enzymes including both 
parasite and host antioxidant enzymes. However, information regarding genetic 
polymorphisms of human antioxidant enzymes with reduced ability to resist oxidative 
stress in malaria is lacking. Such information is necessary, especially in evaluating new 
treatment options as well as in interpreting and predicting associated adverse effects.  
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In chapter 4 we classified falciparum ABC transporters. We showed that 11 out 
of 16 encoded ABC proteins are membrane transporters. Furthermore, we showed that 
PfMRP1, PfMRP2, and PfMDR5 are located on the plasma membrane of the parasite. 
Further functional characterization of these transporters can offer important 
information for drug targeting. This is the first report on the cloning and localization of 
PfMDR5. As opposed to PfMRP1 and 2 there are no studies on the role of PfMDR5 in 
drug susceptibility or on existence of polymorphisms. Other falciparum MDR proteins 
have been associated with resistance to drugs (PfMDR1) or to heavy metals (PfMDR2) 
(Reed et al., 2000; Rosenberg et al., 2006). Therefore it is interesting for future studies 
to investigate the role of PfMDR5 in drug susceptibility.  
Functional characterization of the PfABC transporters requires overexpression of 
the protein. Frequently, expression of proteins in their natural hosts is too low for 
functional studies and proper controls are missing, therefore heterologous expression is 
necessary. In chapter 5 we attempted heterologous expression of the PfABC 
transporters and reported on the effect of gene size and A/T richness in expression of 
PfMDR5. These factors have been reported elsewhere (Mehlin et al., 2006) and have 
been hampering characterization of P. falciparum proteins. Several techniques have 
been used to express other P. falciparum proteins. These include codon optimization, 
codon harmonization, supplementation of rare tRNAs, truncation of nonfunctional low 
structural complexity regions, use of molecular chaperones and transcriptional 
promoters (Birkholtz et al., 2008). Each of these strategies seems to work either 
individually or in combination with others but there is not one standard procedure 
(LaCount et al., 2009; Mehlin et al., 2006; Burgess-Brown et al., 2008) as the genes 
differ from each other in composition, size and structure. Some genes have been 
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expressed successfully in their native forms in certain expression systems, but not in 
others. For instance expression of PfMDR1 has been successful in Xenopus laevis 
oocytes in the native form (Sanchez et al., 2008), while in yeast it required codon 
optimization (Lekostaj et al., 2008; Amoah et al., 2007). PfCRT was also expressed in 
yeast after codon optimization and modification of the N- and C-termini (Zhang et al., 
2002). Nevertheless, based on the present knowledge it is still difficult to predict the 
success of overexpression of a specific gene in a specific host, even after performing 
some modifications. This is perhaps the reason why only few large falciparum proteins 
have been expressed to date.  
 
6.2 Heterologous expression of P. falciparum proteins: future 
perspectives  
Heterologous expression of P. falciparum genes remains a challenging problem. 
The most successful targets are usually small peptides intended for vaccine research and 
the number of successful large membrane targets remains very small (Table 6.1). There 
are several hosts that have been characterized and used for heterologous expression of 
falciparum genes. These include yeast species Pichia pastoris and Sacharomyces 
cerevisiae; mammalian cells such as COS, HEK293, HeLa and CHO cells; baculovirus 
expression system; Xenopus laevis oocyte system; Escherichia coli; Dictyostelium 
discoideum and cell free systems such as wheat germ (wheat embryo).  
6.2.1 Expression in E. coli 
Expression of P. falciparum proteins in E.coli has centered mainly in production 
of short peptides for vaccine development. Despite the simplicity of E. coli as a 
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prokaryotic system and the well characterized molecular biology, limitations have 
included expression of insoluble proteins which sequester in inclusion bodies, 
truncation of proteins, codon bias and amino acid substitutions, toxicity of falciparum 
proteins, more basic isoelectric point of proteins and lack of homology to E. coli 
proteins. Others are prevalence of codons rare in E. coli, signal peptides and presence of 
low complexity region (Mehlin et al., 2006; Aguiar et al., 2004; Vedadi et al., 2007). 
Improvement of the E. coli system for heterologous expression has continued and 
several falciparum vaccine peptides have been produced successfully. The 448 amino 
acid large Pfs48/45 protein has been coexpressed with four periplasmic folding catalysts 
(Outchkourov et al., 2008). Expression of this protein was also succesful after codon 
harmonization (Chowdhury et al., 2009). In both cases, however, the N- and C-terminal 
hydrophobic regions were deleted in the expression constructs. It still remains 
challenging to express in this system large and multidomain integral membrane 
proteins, like the ABC transporters, that require multiple membrane spanning helixes 
and complex folding. Use of molecular chaperones co-expressed with the protein of 
interest is a promising method of improving protein solubility and folding (Outchkourov 
et al., 2008; Tolia and Joshua-Tor, 2006; de Marco and De Marco, 2004). Another 
method is the use of chaotropic reagents to refold improperly folded proteins. In vitro 
protein refolding made it possible to produce sufficient amount of functional P. 
falciparum cysteine protease falcipain-1 (31 kDa fragment) (Kumar et al., 2007) and a 
42 kDa merozoite surface protein (MSP)-1 (Leung et al., 2004). Until now expression of 
a full-length integral membrane protein in E. coli has been unsuccessful.  
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6.2.2 Expression in yeast 
Yeast species commonly used for protein expression are Pichia pastoris and 
Sacharomyces cerevisiae. S. cerevisiae is often the species of choice because it is well 
characterized and relatively easy to use for genetic manipulation (Dominguez et al., 
1998). Advantages of using yeast as protein expression host are high yield , secretion of 
the proteins into the culture medium thus simplifying purification procedures, and the 
relatively easy to perform functional complementation experiments. Disadvantages of 
using yeast for falciparum protein expression include yeast recognition of A/T stretches 
as termination signals that leads to truncated proteins. Also high yield expressions may 
lead to accumulation of improperly folded proteins that are nonfunctional, as well as 
unwanted O- and N-glycosylation (Tanner and Lehle, 1987; Arnold and Tanner, 1982). 
Nevertheless, an enormous number of malaria vaccine peptides have successfully been 
expressed in yeast. Moreover, expression of PfCRT was successful in P. pastoris after 
codon harmonization and removal of A/T stretches. This was the first full-length 
malarial integral membrane protein to be expressed in yeast (Zhang et al., 2002). 
Subsequently, codon optimized PfMDR1 was expressed in the same species of yeast 
(Amoah et al., 2007). Further improvement of yeast as expression host of choice for P 
falciparum genes has continued. In a recent study, recognition of A/T rich regions as 
mRNA termination signal and truncation of proteins was circumvented by selection of 
host cells lacking the enzymes involved in these processes (LaCount et al., 2009). 
Compared to the E. coli system, P. pastoris was proven to be superior as expressed 
proteins were more soluble and elicited stronger immunological responses (Yadava and 
Ockenhouse, 2003). 
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6.2.3 Baculovirus expression system   
Expression using baculovirus infected insect cells is another alternative system 
for falciparum protein expression. Baculovirus Autographa californica nuclear 
polyhedrosis virus and the Spodoptera frugiperda (Sf9 or Sf21) insect cells are 
commonly used. High levels of soluble and properly folded proteins can be achieved in 
this system. For instance proteins that could not be expressed or were expressed in an 
insoluble form in E. coli were shown to express in the soluble forms in the baculovirus 
expression system (Mehlin et al., 2006). Production of P. berghei circumsporozoite 
(PbCSP) protein was successful in this system and the protein stimulated strong 
immunological protection against P. berghei sporozoite challenge in mice (Yoshida et 
al., 2009). In some cases, the baculovirus expression system was preferred over the 
yeast expression system.  For instance, PfMSP-1 expressed in yeast was improperly 
folded and inactive, whereas in the baculovirus expression system it was in the native 
conformation and active (Chang et al., 1992; Pizarro et al., 2003). Proper folding of 
proteins may not be a big problem as large integral membrane proteins are readily 
produced in this system. However, there is no report on full-length expression of a large 
falciparum integral membrane protein in this system. Factors such as codon bias and 
effect of low complexity regions as well as glycosylation patterns are yet to be addressed 
(Kost et al., 2005; Birkholtz et al., 2008).  
6.2.4 Dictyostelium discoideum 
The A/T richness of D. discoideum is similar to that of P. falciparum and makes 
it an attractive heterologous expression system for falciparum genes (Szafranski et al., 
2005). Other attractive factors include ease of its culturing, genetic manipulation, 
presence of basic organelles and well known molecular biology. A full-length 
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circumsporozoite protein (PfCSP) was successfully expressed in this system (van 
Bemmelen et al., 2000). More importantly, mutant and wild-type PfCRT were expressed 
and characterized in D. discoideum, which proves this host to be suitable for integral 
membrane proteins expression (Naude et al., 2005). This system remains a promising 
tool for falciparum large proteins expression and further exploration is encouraged.  
6.2.5 Xenopus laevis oocytes 
This system has several attractive features that make it suitable for falciparum 
protein expression. Oocytes are especially suitable for transport assays. Moreover, it 
seems to handle well the A/T richness of the P. falciparum as several genes are 
expressed without codon optimization. The simplicity of an oocyte as an 
undifferentiated cell may offer versatile abilities to handle foreign genes. Several 
falciparum membrane proteins have been successfully expressed in this system, 
including the hexose transporter-1 (PfHT-1), the SERCA ATPase (PfATase6), 
PfATPase4, and PfMDR1 (Sanchez et al., 2008; Krishna et al., 2001; Penny et al., 1998; 
Woodrow et al., 1999; Eckstein-Ludwig et al., 2003). This is the system that is most 
successful in expression of large falciparum membrane proteins. The most important 
limitations of oocytes involve the laborious injection procedure, seasonal variability of 
oocytes, and little amount of protein produced (Birkholtz et al., 2008; Vargas et al., 
2004). 
6.2.6 Mammalian cells 
Mammalian cell expression systems have been used for successful expression of 
several falciparum peptides used for vaccine development such as AMA-1, Duffy binding 
protein, and PfEMP-1 (Birkholtz et al., 2008). Commonly used cells include Chinese 
Hamster Ovary (CHO) cells, simian COS and human HeLa and HEK293 cells. Some 
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integral membrane proteins have been successfully expressed in mammalian cells. 
PfMDR1 was reported to express in CHO cells (Van Es et al., 1994) and both mutant and 
wild-type PfCRT were expressed and functionally studied in HEK293 cells (Reeves et al., 
2006). Low protein expression levels and difficulty of producing functionally 
compromised mutants for complementation experiments are examples of the challenges 
(Birkholtz et al., 2008). 
6.2.7 Cell free systems 
Use of the wheat germ expression system is a recently developed method (Vinarov et al., 
2006). This system carries some advantages over living cell. Some of the advantages 
include the prior propagation of host cells without the gene of interest, thus avoiding 
potential inhibition of cell propagation in case of gene toxicity. Also the in vitro, open 
state of a cell free system allows varying reaction conditions for instance volumes, 
temperature, reagents, and kinetics (Mudeppa et al., 2007). In this system P. 
falciparum dihydrofolate reductase (PfDHFR) that failed to express in other systems 
due to toxicity, was successful functionally expressed (Mudeppa et al., 2007). Many 
other malarial proteins including Pfs25, PfCSP, and PfAMA-1 were expressed in large 
quantities, both in their native and codon optimized forms (Tsuboi et al., 2008). This 
system is a promising tool and alternative for falciparum protein expression but its 
suitability for membrane proteins especially for functional assays needs to be 
determined. Factors such as gene size, presence of low complexity regions and 
isoelectric point of the proteins are factors noted to affect protein expression in cell free 
system (Birkholtz et al., 2008).  
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Table 6.1: Examples of successful P. falciparum integral membrane protein expression in 
various heterologous systems. 
 
Heterologous system  
 
Successful full-length integral 
membrane targets 
 
Codon 
optimization 
     
P. pastoris PfMDR1 and PfCRT PfMDR1 and 
PfCRT 
Mammalian cells PfMDR1 (in CHO cells) and  PfCRT (in 
HEK293) 
PfCRT 
   
Xenopus laevis oocytes PfHT-1, PfATPase4, PfATPase6, and PfMDR1  
   
Dictyostelium 
discoideum 
PfCRT  
   
 
Compared to the time when this thesis project was initiated, the amount of 
information that is now available regarding heterologous expression of falciparum 
proteins has increased enormously and future research will benefit more from this 
knowledge. Based on the discussion above, Xenopus laevis oocytes, yeast, and 
mammalian cell expression systems have demonstrated to be suitable choices for 
falciparum protein expression. Yeast and Xenopus laevis oocytes are the leading to date 
in terms of the number of successfully expressed targets, while D. discoideum and wheat 
germ are new promising systems. The baculovirus is another alternative that needs 
more exploration. However, each system has its advantages and disadvantages and 
currently there is no single standard heterologous protein expression system for P. 
falciparum. There is an urgent need for an optimal standard expression system for P. 
falciparum proteins that may be achieved through continued optimization.  
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Summary 
Malaria has remained an enormous health problem worldwide with highest 
morbidity and mortality among all infectious diseases. The emergence of multidrug 
resistant parasites and the lack of effective vaccines are major obstacles to malaria 
control. The molecular mechanisms involved in drug resistance evolution are complex 
and involve multiple genes. They range from alternative glutathione-dependent heme 
detoxification to active efflux of antimalarial drugs from the parasite. Current literature 
data implicate glutathione (GSH) as an important antioxidant in parasite survival as 
well as in drug resistance pathways. While increased cellular oxidative stress accelerates 
parasite clearance, malaria-induced oxidative stress is also known to exacerbate the 
pathology. Thus antioxidant status of the host cell may be important in determining 
clinical outcome of the infection. Several antioxidant enzyme systems exist in the 
parasite as well as in the host cell. Glutathione transferases (GSTs) are both phase-II 
detoxification and antioxidant enzymes. They use GSH to function as peroxidases and 
also conjugate drugs with GSH thereby predisposing them for efflux by ATP-binding 
cassette (ABC) transporters. The aim of this thesis was to investigate the role of  GST 
polymorphisms in susceptibility to severe falciparum malaria and to clone, express and 
characterize putative ABC transporters of P. falciparum. 
In chapter 2 and 3 using multiplex and RFLP (Restriction fragment length 
polymorphism) PCR we determined the prevalence of GST mu (GSTM1), pi (GSTP1), 
and theta (GSTT1) genotypic polymorphisms in severe versus mild malaria cases. Severe 
malaria classification was based on the WHO criteria. The study in chapter 2 was 
performed on DNA samples from Cameroonian children where the severe malaria group 
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was mostly characterized with hyperpyrexia, severe anemia, respiratory distress, and 
coma. In our results GSTM1-null genotype was significantly higher in severe versus mild 
malaria cases. GSTP1 and GSTT1 did not vary between the two groups. In chapter 3 we 
determined the same GST polymorphisms in Tanzanian children. The severe malaria 
group was mainly characterized by severe anemia. We observed a significantly higher 
prevalence of the GSTP1-I105V genotype in severe than in mild malaria. The GSTM1-
null genotype was also higher in the severe malaria group, but the difference was not 
significant. We concluded that GSTM1-null and GSTP1-I105V genotypic variants are 
associated with severe malaria in children.  
In chapter 4 we used bioinformatics techniques to retrieve and phylogenetically 
classify P. falciparum ABC proteins from the Plasmodium database. We show that 11 
out of 16 genome encoded ABC proteins are membrane transporters. Furthermore, we 
determined the sub-cellular localization of PfMRP1 (Plasmodium falciparum Mutidrug 
Resistance-associated Protein 1), PfMRP2, and PfMDR5 (Plasmodium falciparum 
MultiDrug Resistance protein 5) in the asexual stages of the parasite using 
immunocytochemistry. We found that all three ABC transporters localized to the 
parasite’s plasma membrane in all asexual stages. There were no localization signals on 
the erythrocyte membrane, parasite food vacuole membrane or in cytoplasmic 
compartments such as endoplasmic reticulum.  
In chapter 5 we cloned and investigated expression of the PfABC transporters in 
various heterologous expression systems. Expression of PfABCB7, PfMRP1, PfMRP2, 
and PfMDR5 was investigated in transduced mammalian cells; baculovirus infected 
insect cells (Sf9) and injected Xenopus laevis oocytes. Expression of codon harmonized 
full-length PfMDR5 and EYFP-PfMDR5 fusion fragments were evaluated in Sf9 and 
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mammalian HeLa cells. We observed a decrease in expression level with increasing size 
of native EYFP-fusion PfMDR5 fragments in both Sf9 and HeLa cells. No expression of 
full-length transporters was observed in any of the systems used. The codon harmonized 
EYFP-PfMDR5 fusion fragment was expressed in slightly higher amounts compared to 
the native form. We concluded that gene size, A/T-richness or codon bias may affect 
expression of falciparum membrane proteins in HeLa and Sf9 cells. Codon 
harmonization may improve expression of falciparum proteins in Sf9 cells. 
In chapter 6 all the results obtained in this thesis have been discussed and put 
into a broader perspective. Our results on GST polymorphisms and susceptibility to 
severe malaria contribute to the knowledge on molecular processes of malaria disease. It 
also stimulates research on the impact of oxidative stress-inducing drugs in individuals 
with reduced or deficient antioxidant enzyme activity, especially in case of multiple 
enzyme deficiencies. Furthermore, our results from chapters 4 and 5 contribute to the 
molecular biology knowledge of the parasite and give more insights into the avenues for 
further characterization of the falciparum ABC transporters as possible antimalarial 
drug targets.   
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Samenvatting  
Malaria is wereldwijd nog steeds een enorm gezondheidsprobleem met de 
hoogste morbiditeit en mortaliteit onder alle infectieziekten. De opkomst van multi-
resistente parasieten en het ontbreken van effectieve vaccins zijn grote obstakels voor de 
bestrijding van malaria. De moleculaire mechanismen die betrokken zijn bij de 
ontwikkeling van resistentie tegen geneesmiddelen zijn complex en omvatten meerdere 
genen. Ze variëren van glutathion-afhankelijke detoxificatie van heem tot actieve efflux 
van antimalariamiddelen uit de parasiet. De huidige literatuurgegevens impliceren dat 
glutathion (GSH) een belangrijke rol speelt als anti-oxidant bij de overleving van de 
parasiet, evenals bij de resistentie tegen geneesmiddelen. Hoewel een toename in 
cellulaire oxidatieve stress de eliminatie van parasieten verhoogt, is het ook bekend dat 
het de pathologie kan verergeren. De anti-oxidantstatus van de gastheercel zou dus het 
klinisch beloop van de infectie kunnen beïnvloeden. Verschillende enzymsystemen die 
oxidanten wegvangen, zijn aanwezig in de parasiet en de gastheercel. Glutathion S-
transferases (GSTs) zijn daarvan een voorbeeld, daarnaast kunnen GSTs 
lichaamsvreemde stoffen ontgiften. Zij maken gebruik van GSH voor hun functie als 
peroxidases en koppelen GSH aan toxische stoffen (fase II-ontgifting) welke vervolgens 
door ATP-binding cassette (ABC) transporters buiten de cel worden getransporteerd. 
Het doel van dit proefschrift was om de rol van GST-polymorfismen in de gevoeligheid 
voor ernstige malariainfecties met Plasmodium falciparum te onderzoeken en tevens 
nieuwe ABC-transporters in P. falciparum te kloneren, tot expressie te brengen en te 
karakteriseren.  
In hoofdstuk 2 en 3 hebben we met behulp van multiplex-PCR en RFLP 
(‘Restriction fragment length polymorphism’) de prevalentie van GST-mu- (GSTM1), -
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pi- (GSTP1) en -theta (GSTT1)-polymorfismen in ernstige versus lichte malariagevallen 
bepaald. De classificatie van ernstige malaria was gebaseerd op de WHO-criteria. De 
studie in hoofdstuk 2 werd uitgevoerd op DNA-monsters van kinderen uit Kameroen, 
waar de ernstige malariagroep meestal gekenmerkt was door zeer hoge koorts, ernstige 
anemie, ademnood, en coma. Wij vonden dat het GSTM1-null-genotype significant 
frequenter voorkwam in ernstige versus lichte malariagevallen. Er was geen verschil 
tussen GSTP1 en GSTT1 in de twee groepen. In hoofdstuk 3 hebben we dezelfde GST-
polymorfismen in Tanzaniaanse kinderen vastgesteld. De ernstige malariagroep werd 
voornamelijk gekenmerkt door ernstige bloedarmoede. We hebben een significant 
hogere prevalentie van het GSTP1-I105V-genotype waargenomen bij de ernstige 
malariagroep in vergelijking met de licht aangedane groep. Het GSTM1-null-genotype 
was ook frequenter aanwezig in de ernstige malariagroep, maar het verschil was niet 
significant. Wij hebben geconcludeerd dat bij kinderen de GSTM1-null- en GSTP1-
I105V-genotypische varianten geassocieerd zijn met ernstige malaria.  
In hoofdstuk 4 gebruiken we bioinformaticatechnieken om P. falciparum ABC-
eiwitten uit de Plasmodium database fylogenetisch te classificeren. We tonen aan dat 11 
van de 16 genoomgecodeerde ABC-eiwitten, membraantransporters zijn. Verder 
bepaalden we de subcellulaire lokalisatie van PfMRP1 (P. falciparum Multidrug 
Resistance-associated Protein 1), PfMRP2 en PfMDR5 (P. falciparum MultiDrug 
Resistance protein 5) in de aseksuele stadia van de parasiet met behulp van 
immunocytochemie. We vonden dat deze drie ABC-transporters op de 
plasmamembraan van de parasiet zijn gelokaliseerd in alle aseksuele stadia. Er waren 
geen signalen aanwezig op de erytrocytmembraan, de voedsel-vacuolemembraan of in 
cytoplasmatische compartimenten zoals het endoplasmatisch reticulum.  
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In hoofdstuk 5 hebben we enkele PfABC-transporters gekloneerd en de 
expressie onderzocht in verschillende heterologe expressiesystemen. De expressie van  
PfABCB7, PfMRP1, PfMRP2 en PfMDR5 werd onderzocht in getransduceerde 
zoogdiercellen, baculovirus-geïnfecteerde insectencellen (Sf9) en geïnjecteerd Xenopus 
laevis-oöcyten. De codon-geharmoniseerde PfMDR5- en EYFP-PfMDR5-
fusiefragmenten werden tot expressie gebracht in het baculovirus-expressiesysteem en 
in humane HeLa-cellen. We zagen een afname van het expressieniveau als het PfMDR5-
fragment groter werd, in Sf9- en HeLa-cellen. Bij geen van de gebruikte systemen  werd 
expressie van de volledige transporters waargenomen. Het codon geharmoniseerde 
EYFP-PfMDR5-fusiefragment werd in iets grotere hoeveelheden tot expressie gebracht 
dan de oorspronkelijke vorm. Wij hebben geconcludeerd dat gengrootte, A/T-rijkdom of 
codonbias van invloed kunnen zijn op de expressie van falciparum membraan eiwitten 
in HeLa- en Sf9-cellen. Codon-harmonisatie kan de expressie van falciparum-eiwitten in 
Sf9-cellen verbeteren.  
In hoofdstuk 6 zijn alle resultaten uit dit proefschrift besproken en in een 
breder perspectief geplaatst. Onze resultaten met betrekking tot GST-polymorfismen en 
de gevoeligheid voor ernstige malaria dragen bij aan de kennis over de moleculaire 
processen van malaria. Het stimuleert ook het onderzoek naar de effecten van oxidatieve 
stress-inducerende geneesmiddelen bij personen met beperkte of gebrekkige 
antioxidant-enzymactiviteit, met name in geval van meerdere enzymdeficiënties. 
Bovendien zullen de resultaten van de hoofdstukken 4 en 5 bijdragen aan de kennis van 
de moleculaire biologie van de parasiet en geven ze meer inzicht in de mogelijkheden 
voor verdere karakterisering van de ABC-transporters in de parasiet als 
aangrijpingspunt voor mogelijke antimalariamiddelen. 
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